JP2000072736A - Benzenecarboxamide compound and gelling agent or solidifying agent for organic liquid - Google Patents
Benzenecarboxamide compound and gelling agent or solidifying agent for organic liquidInfo
- Publication number
- JP2000072736A JP2000072736A JP10246965A JP24696598A JP2000072736A JP 2000072736 A JP2000072736 A JP 2000072736A JP 10246965 A JP10246965 A JP 10246965A JP 24696598 A JP24696598 A JP 24696598A JP 2000072736 A JP2000072736 A JP 2000072736A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- valyl
- group
- cox
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 Benzenecarboxamide compound Chemical class 0.000 title claims abstract description 114
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 20
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzene carboxamide Natural products NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 title claims abstract description 5
- 239000007788 liquid Substances 0.000 title claims description 21
- 239000003349 gelling agent Substances 0.000 title abstract description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 35
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 32
- 125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 claims description 28
- 125000004432 carbon atom Chemical group C* 0.000 claims description 25
- 125000002061 L-isoleucyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](C([H])([H])[H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims description 17
- 125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 claims description 15
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims description 13
- 150000001413 amino acids Chemical class 0.000 abstract description 9
- 238000000034 method Methods 0.000 abstract description 9
- 239000002904 solvent Substances 0.000 abstract description 7
- 239000010687 lubricating oil Substances 0.000 abstract description 5
- 229910052751 metal Inorganic materials 0.000 abstract description 4
- 239000002184 metal Substances 0.000 abstract description 4
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 abstract description 3
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 239000000976 ink Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 150000003973 alkyl amines Chemical class 0.000 abstract description 2
- 238000000576 coating method Methods 0.000 abstract description 2
- 229920001971 elastomer Polymers 0.000 abstract description 2
- 239000000835 fiber Substances 0.000 abstract description 2
- 150000002739 metals Chemical class 0.000 abstract description 2
- 229920000642 polymer Polymers 0.000 abstract description 2
- 239000005060 rubber Substances 0.000 abstract description 2
- KCIRAFQAHRTJEJ-UWXQCODUSA-N 1-n,2-n-bis[(2s)-2-amino-3-methylbutanoyl]-1-n,2-n-didodecylbenzene-1,2-dicarboxamide Chemical compound CCCCCCCCCCCCN(C(=O)[C@@H](N)C(C)C)C(=O)C1=CC=CC=C1C(=O)N(CCCCCCCCCCCC)C(=O)[C@@H](N)C(C)C KCIRAFQAHRTJEJ-UWXQCODUSA-N 0.000 abstract 1
- 101100037762 Caenorhabditis elegans rnh-2 gene Proteins 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 description 30
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 23
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 21
- 229940024606 amino acid Drugs 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical group CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 13
- FYXKZNLBZKRYSS-UHFFFAOYSA-N benzene-1,2-dicarbonyl chloride Chemical compound ClC(=O)C1=CC=CC=C1C(Cl)=O FYXKZNLBZKRYSS-UHFFFAOYSA-N 0.000 description 13
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical group CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 12
- 239000000499 gel Substances 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- CANZBRDGRHNSGZ-NSHDSACASA-N (2s)-3-methyl-2-(phenylmethoxycarbonylamino)butanoic acid Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 CANZBRDGRHNSGZ-NSHDSACASA-N 0.000 description 8
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical group CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- LXEJRKJRKIFVNY-UHFFFAOYSA-N terephthaloyl chloride Chemical group ClC(=O)C1=CC=C(C(Cl)=O)C=C1 LXEJRKJRKIFVNY-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 7
- 239000002699 waste material Substances 0.000 description 7
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 6
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- UJMDYLWCYJJYMO-UHFFFAOYSA-N benzene-1,2,3-tricarboxylic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1C(O)=O UJMDYLWCYJJYMO-UHFFFAOYSA-N 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- KKEYFWRCBNTPAC-UHFFFAOYSA-N benzene-dicarboxylic acid Natural products OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 5
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- FDQSRULYDNDXQB-UHFFFAOYSA-N benzene-1,3-dicarbonyl chloride Chemical group ClC(=O)C1=CC=CC(C(Cl)=O)=C1 FDQSRULYDNDXQB-UHFFFAOYSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 229950003188 isovaleryl diethylamide Drugs 0.000 description 4
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 4
- JSHXJPFZKBRLFU-JQWIXIFHSA-N (2s,3s)-3-methyl-2-(phenylmethoxycarbonylamino)pentanoic acid Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 JSHXJPFZKBRLFU-JQWIXIFHSA-N 0.000 description 3
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 3
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 3
- IIGPLNZCFGACKB-UHFFFAOYSA-N 2-amino-n-octadecylacetamide Chemical compound CCCCCCCCCCCCCCCCCCNC(=O)CN IIGPLNZCFGACKB-UHFFFAOYSA-N 0.000 description 3
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical group C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- USPFMEKVPDBMCG-LBPRGKRZSA-N N-benzyloxycarbonyl-L-leucine Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 USPFMEKVPDBMCG-LBPRGKRZSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000010775 animal oil Substances 0.000 description 3
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- UWCPYKQBIPYOLX-UHFFFAOYSA-N benzene-1,3,5-tricarbonyl chloride Chemical group ClC(=O)C1=CC(C(Cl)=O)=CC(C(Cl)=O)=C1 UWCPYKQBIPYOLX-UHFFFAOYSA-N 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- FMZUHGYZWYNSOA-VVBFYGJXSA-N (1r)-1-[(4r,4ar,8as)-2,6-diphenyl-4,4a,8,8a-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-4-yl]ethane-1,2-diol Chemical compound C([C@@H]1OC(O[C@@H]([C@@H]1O1)[C@H](O)CO)C=2C=CC=CC=2)OC1C1=CC=CC=C1 FMZUHGYZWYNSOA-VVBFYGJXSA-N 0.000 description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 2
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 2
- DLKFVXARQLYXQT-QFIPXVFZSA-N (2s)-2-amino-3-methyl-n-octadecylbutanamide Chemical compound CCCCCCCCCCCCCCCCCCNC(=O)[C@@H](N)C(C)C DLKFVXARQLYXQT-QFIPXVFZSA-N 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 2
- MZIUPHBAHISRBN-WLTNIFSVSA-N 1-N,4-N-bis[(2S)-2-amino-3-methylbutanoyl]-1-N,4-N-dioctadecylbenzene-1,4-dicarboxamide Chemical compound C(C1=CC=C(C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCC)C=C1)(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCC MZIUPHBAHISRBN-WLTNIFSVSA-N 0.000 description 2
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 2
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 2
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 2
- LAIUFBWHERIJIH-UHFFFAOYSA-N 3-Methylheptane Chemical compound CCCCC(C)CC LAIUFBWHERIJIH-UHFFFAOYSA-N 0.000 description 2
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 2
- OMYDRPNYPXYONR-KRWDZBQOSA-N CC(C)C[C@@H](C(=O)CCCCCCCCCCCCN)N Chemical compound CC(C)C[C@@H](C(=O)CCCCCCCCCCCCN)N OMYDRPNYPXYONR-KRWDZBQOSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- QMKYBPDZANOJGF-UHFFFAOYSA-N benzene-1,3,5-tricarboxylic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC(C(O)=O)=C1 QMKYBPDZANOJGF-UHFFFAOYSA-N 0.000 description 2
- 229960004365 benzoic acid Drugs 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 229940125797 compound 12 Drugs 0.000 description 2
- 229940126208 compound 22 Drugs 0.000 description 2
- 229940125846 compound 25 Drugs 0.000 description 2
- 229940125851 compound 27 Drugs 0.000 description 2
- 229940127204 compound 29 Drugs 0.000 description 2
- 229940125936 compound 42 Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 125000001998 leucyl group Chemical group 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- ARCGXLSVLAOJQL-UHFFFAOYSA-N trimellitic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 ARCGXLSVLAOJQL-UHFFFAOYSA-N 0.000 description 2
- 125000002114 valyl group Chemical group 0.000 description 2
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 1
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 1
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 1
- FWXXKRKQULIXRL-GOTSBHOMSA-N (2s,3s)-2-amino-3-methyl-n-octadecylpentanamide Chemical compound CCCCCCCCCCCCCCCCCCNC(=O)[C@@H](N)[C@@H](C)CC FWXXKRKQULIXRL-GOTSBHOMSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 1
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 1
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 1
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 1
- COQIWLXONHFWES-UHFFFAOYSA-N 2-amino-n-dodecylacetamide Chemical compound CCCCCCCCCCCCNC(=O)CN COQIWLXONHFWES-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- BGAJNPLDJJBRHK-UHFFFAOYSA-N 3-[2-[5-(3-chloro-4-propan-2-yloxyphenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-6,7-dihydro-4h-pyrazolo[4,3-c]pyridin-5-yl]propanoic acid Chemical compound C1=C(Cl)C(OC(C)C)=CC=C1C1=NN=C(N2C(=C3CN(CCC(O)=O)CCC3=N2)C)S1 BGAJNPLDJJBRHK-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- ZOWTVSKIEROIFP-UHFFFAOYSA-N C(C1=CC(C(=O)N(C(C(N)C(C)C)=O)CCCCCCCCCCCCCCCCCC)=CC=C1)(=O)N(C(C(N)C(C)C)=O)CCCCCCCCCCCCCCCCCC Chemical compound C(C1=CC(C(=O)N(C(C(N)C(C)C)=O)CCCCCCCCCCCCCCCCCC)=CC=C1)(=O)N(C(C(N)C(C)C)=O)CCCCCCCCCCCCCCCCCC ZOWTVSKIEROIFP-UHFFFAOYSA-N 0.000 description 1
- PZUBXGLIIRYFSH-UHFFFAOYSA-N C(C1=CC(C(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC)=CC=C1)(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC Chemical compound C(C1=CC(C(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC)=CC=C1)(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC PZUBXGLIIRYFSH-UHFFFAOYSA-N 0.000 description 1
- ZOWTVSKIEROIFP-WLTNIFSVSA-N C(C1=CC(C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCC)=CC=C1)(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCC Chemical compound C(C1=CC(C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCC)=CC=C1)(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCC ZOWTVSKIEROIFP-WLTNIFSVSA-N 0.000 description 1
- POGCVIIMFHNOQQ-KEAHXZLPSA-N C(C1=CC(C(=O)N(C([C@@H](N)[C@@H](C)CC)=O)CCCCCCCCCCCC)=CC=C1)(=O)N(C([C@@H](N)[C@@H](C)CC)=O)CCCCCCCCCCCC Chemical compound C(C1=CC(C(=O)N(C([C@@H](N)[C@@H](C)CC)=O)CCCCCCCCCCCC)=CC=C1)(=O)N(C([C@@H](N)[C@@H](C)CC)=O)CCCCCCCCCCCC POGCVIIMFHNOQQ-KEAHXZLPSA-N 0.000 description 1
- MZIUPHBAHISRBN-UHFFFAOYSA-N C(C1=CC=C(C(=O)N(C(C(N)C(C)C)=O)CCCCCCCCCCCCCCCCCC)C=C1)(=O)N(C(C(N)C(C)C)=O)CCCCCCCCCCCCCCCCCC Chemical compound C(C1=CC=C(C(=O)N(C(C(N)C(C)C)=O)CCCCCCCCCCCCCCCCCC)C=C1)(=O)N(C(C(N)C(C)C)=O)CCCCCCCCCCCCCCCCCC MZIUPHBAHISRBN-UHFFFAOYSA-N 0.000 description 1
- WEIIFDTZECKEPI-UHFFFAOYSA-N C(C1=CC=C(C(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC)C=C1)(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC Chemical compound C(C1=CC=C(C(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC)C=C1)(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC WEIIFDTZECKEPI-UHFFFAOYSA-N 0.000 description 1
- HKFJWLSPGGXSQB-COCZKOEFSA-N C(C1=CC=C(C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCC)C=C1)(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCC Chemical compound C(C1=CC=C(C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCC)C=C1)(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCC HKFJWLSPGGXSQB-COCZKOEFSA-N 0.000 description 1
- ZKYBSUBSCASSNL-ZYBCLOSLSA-N C(C1=CC=C(C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCC)C=C1)(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCC Chemical compound C(C1=CC=C(C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCC)C=C1)(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCC ZKYBSUBSCASSNL-ZYBCLOSLSA-N 0.000 description 1
- ZRPCIXJADFJBLG-PJYGOTMFSA-N C(C1=CC=C(C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCCCC)C=C1)(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCCCC Chemical compound C(C1=CC=C(C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCCCC)C=C1)(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCCCC ZRPCIXJADFJBLG-PJYGOTMFSA-N 0.000 description 1
- LTHNANVAEAAVJX-YQOHNZFASA-N C(C1=CC=C(C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCCCCCC)C=C1)(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCCCCCC Chemical compound C(C1=CC=C(C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCCCCCC)C=C1)(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCCCCCC LTHNANVAEAAVJX-YQOHNZFASA-N 0.000 description 1
- BEXBTHGNEXTFLI-ZAQUEYBZSA-N C(C1=CC=C(C(=O)N(C([C@@H](N)C)=O)CCCCCCCCCCCCCCCC)C=C1)(=O)N(C([C@@H](N)C)=O)CCCCCCCCCCCCCCCC Chemical compound C(C1=CC=C(C(=O)N(C([C@@H](N)C)=O)CCCCCCCCCCCCCCCC)C=C1)(=O)N(C([C@@H](N)C)=O)CCCCCCCCCCCCCCCC BEXBTHGNEXTFLI-ZAQUEYBZSA-N 0.000 description 1
- UDZNHFGHLBKDMT-XWQGWOARSA-N C(C1=CC=C(C(=O)N(C([C@@H](N)CC(C)C)=O)CCCCCCCCCCCCCCCCCC)C=C1)(=O)N(C([C@@H](N)CC(C)C)=O)CCCCCCCCCCCCCCCCCC Chemical compound C(C1=CC=C(C(=O)N(C([C@@H](N)CC(C)C)=O)CCCCCCCCCCCCCCCCCC)C=C1)(=O)N(C([C@@H](N)CC(C)C)=O)CCCCCCCCCCCCCCCCCC UDZNHFGHLBKDMT-XWQGWOARSA-N 0.000 description 1
- NAIRDLCWETZFMK-UHFFFAOYSA-N C(C=1C(C(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC)=CC=CC1)(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC Chemical compound C(C=1C(C(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC)=CC=CC1)(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC NAIRDLCWETZFMK-UHFFFAOYSA-N 0.000 description 1
- KAHBDIKPRIEBIE-WLTNIFSVSA-N C(C=1C(C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCC)=CC=CC1)(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCC Chemical compound C(C=1C(C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCC)=CC=CC1)(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCCCCCCCC KAHBDIKPRIEBIE-WLTNIFSVSA-N 0.000 description 1
- RTZRNEBSQVKXIC-WBLNBYGBSA-N C(C=1C(C(=O)N(C([C@@H](N)CC(C)C)=O)CCCCCCCCCCCCCCCCCCCCCC)=CC=CC1)(=O)N(C([C@@H](N)CC(C)C)=O)CCCCCCCCCCCCCCCCCCCCCC Chemical compound C(C=1C(C(=O)N(C([C@@H](N)CC(C)C)=O)CCCCCCCCCCCCCCCCCCCCCC)=CC=CC1)(=O)N(C([C@@H](N)CC(C)C)=O)CCCCCCCCCCCCCCCCCCCCCC RTZRNEBSQVKXIC-WBLNBYGBSA-N 0.000 description 1
- KOYQWFDGZXEMSI-KEAHXZLPSA-N C(C=1C(C(=O)N(C([C@@H](N)[C@@H](C)CC)=O)CCCCCCCCCCCC)=CC=CC1)(=O)N(C([C@@H](N)[C@@H](C)CC)=O)CCCCCCCCCCCC Chemical compound C(C=1C(C(=O)N(C([C@@H](N)[C@@H](C)CC)=O)CCCCCCCCCCCC)=CC=CC1)(=O)N(C([C@@H](N)[C@@H](C)CC)=O)CCCCCCCCCCCC KOYQWFDGZXEMSI-KEAHXZLPSA-N 0.000 description 1
- IVYODQWHPZKGIK-UHFFFAOYSA-N C1(=CC(=CC(=C1)C(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC)C(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC)C(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC Chemical compound C1(=CC(=CC(=C1)C(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC)C(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC)C(=O)N(C(C(N)CC(C)C)=O)CCCCCCCCCCCCCC IVYODQWHPZKGIK-UHFFFAOYSA-N 0.000 description 1
- XSBRXHMKFIJGEB-LKDKIUHVSA-N C1(=CC(=CC(=C1)C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCC)C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCC)C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCC Chemical compound C1(=CC(=CC(=C1)C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCC)C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCC)C(=O)N(C([C@@H](N)C(C)C)=O)CCCCCCCCCCCC XSBRXHMKFIJGEB-LKDKIUHVSA-N 0.000 description 1
- KHFIZSHIPJDFGJ-BSNUEQINSA-N C1(=CC(=CC(=C1)C(=O)N(C([C@@H](N)C)=O)CCCCCCCCCCCCCCCC)C(=O)N(C([C@@H](N)C)=O)CCCCCCCCCCCCCCCC)C(=O)N(C([C@@H](N)C)=O)CCCCCCCCCCCCCCCC Chemical compound C1(=CC(=CC(=C1)C(=O)N(C([C@@H](N)C)=O)CCCCCCCCCCCCCCCC)C(=O)N(C([C@@H](N)C)=O)CCCCCCCCCCCCCCCC)C(=O)N(C([C@@H](N)C)=O)CCCCCCCCCCCCCCCC KHFIZSHIPJDFGJ-BSNUEQINSA-N 0.000 description 1
- UWEJQTJZMARLNU-BSNUEQINSA-N C1(=CC(=CC(=C1)C(=O)N(C([C@@H](N)CC(C)C)=O)CCCCCCCCCCCC)C(=O)N(C([C@@H](N)CC(C)C)=O)CCCCCCCCCCCC)C(=O)N(C([C@@H](N)CC(C)C)=O)CCCCCCCCCCCC Chemical compound C1(=CC(=CC(=C1)C(=O)N(C([C@@H](N)CC(C)C)=O)CCCCCCCCCCCC)C(=O)N(C([C@@H](N)CC(C)C)=O)CCCCCCCCCCCC)C(=O)N(C([C@@H](N)CC(C)C)=O)CCCCCCCCCCCC UWEJQTJZMARLNU-BSNUEQINSA-N 0.000 description 1
- AWWOEIOATYQOFO-UHFFFAOYSA-N CC(C)C(C(=O)CCCCCCCCCCCCCCCCCCN)N Chemical compound CC(C)C(C(=O)CCCCCCCCCCCCCCCCCCN)N AWWOEIOATYQOFO-UHFFFAOYSA-N 0.000 description 1
- IQHXASJIQRZOHF-FWYJNYDBSA-N CCCCC(CC)CN(C(=O)C1=CC(=CC=C1)C(=O)N(CC(CC)CCCC)C(=O)[C@H](C(C)C)N)C(=O)[C@H](C(C)C)N Chemical compound CCCCC(CC)CN(C(=O)C1=CC(=CC=C1)C(=O)N(CC(CC)CCCC)C(=O)[C@H](C(C)C)N)C(=O)[C@H](C(C)C)N IQHXASJIQRZOHF-FWYJNYDBSA-N 0.000 description 1
- XZXVJFVGEXZYKE-FWYJNYDBSA-N CCCCC(CC)CN(C(=O)C1=CC=CC=C1C(=O)N(CC(CC)CCCC)C(=O)[C@H](C(C)C)N)C(=O)[C@H](C(C)C)N Chemical compound CCCCC(CC)CN(C(=O)C1=CC=CC=C1C(=O)N(CC(CC)CCCC)C(=O)[C@H](C(C)C)N)C(=O)[C@H](C(C)C)N XZXVJFVGEXZYKE-FWYJNYDBSA-N 0.000 description 1
- XMDDFSCPIRTTDN-CCHLYJDOSA-N CCCCC(CC)CN(C([C@H](C(C)C)N)=O)C(C1=CC(C(N(CC(CC)CCCC)C([C@H](C(C)C)N)=O)=O)=CC(C(N(CC(CC)CCCC)C([C@H](C(C)C)N)=O)=O)=C1)=O Chemical compound CCCCC(CC)CN(C([C@H](C(C)C)N)=O)C(C1=CC(C(N(CC(CC)CCCC)C([C@H](C(C)C)N)=O)=O)=CC(C(N(CC(CC)CCCC)C([C@H](C(C)C)N)=O)=O)=C1)=O XMDDFSCPIRTTDN-CCHLYJDOSA-N 0.000 description 1
- DLKFVXARQLYXQT-UHFFFAOYSA-N CCCCCCCCCCCCCCCCCCNC(=O)C(N)C(C)C Chemical compound CCCCCCCCCCCCCCCCCCNC(=O)C(N)C(C)C DLKFVXARQLYXQT-UHFFFAOYSA-N 0.000 description 1
- BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229940126639 Compound 33 Drugs 0.000 description 1
- 229940127007 Compound 39 Drugs 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CJUMAFVKTCBCJK-UHFFFAOYSA-N N-benzyloxycarbonylglycine Chemical compound OC(=O)CNC(=O)OCC1=CC=CC=C1 CJUMAFVKTCBCJK-UHFFFAOYSA-N 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- IBNSOHGUXAWCBW-QHCPKHFHSA-N N[C@@H](CC(C)C)C(=O)CCCCCCCCCCCCCCCCCCN Chemical compound N[C@@H](CC(C)C)C(=O)CCCCCCCCCCCCCCCCCCN IBNSOHGUXAWCBW-QHCPKHFHSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 125000001980 alanyl group Chemical group 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 1
- SXHLEIFYCANFJQ-UHFFFAOYSA-N benzene-1,2,4-tricarboxamide Chemical compound NC(=O)C1=CC=C(C(N)=O)C(C(N)=O)=C1 SXHLEIFYCANFJQ-UHFFFAOYSA-N 0.000 description 1
- WXWQVSOHWXJBDF-UHFFFAOYSA-N benzene-1,3,5-tricarboxamide Chemical class NC(=O)C1=CC(C(N)=O)=CC(C(N)=O)=C1 WXWQVSOHWXJBDF-UHFFFAOYSA-N 0.000 description 1
- JRFMZTLWVBLNLM-UHFFFAOYSA-N benzene-1,3-dicarboxylic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1.OC(=O)C1=CC=CC(C(O)=O)=C1 JRFMZTLWVBLNLM-UHFFFAOYSA-N 0.000 description 1
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 229940125961 compound 24 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125877 compound 31 Drugs 0.000 description 1
- 229940125807 compound 37 Drugs 0.000 description 1
- 229940127573 compound 38 Drugs 0.000 description 1
- 229940126540 compound 41 Drugs 0.000 description 1
- 229940125844 compound 46 Drugs 0.000 description 1
- 229940127271 compound 49 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 239000008162 cooking oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 229940087101 dibenzylidene sorbitol Drugs 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000295 fuel oil Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 description 1
- 125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 description 1
- 125000001196 nonadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- ZWPWUVNMFVVHHE-UHFFFAOYSA-N terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1.OC(=O)C1=CC=C(C(O)=O)C=C1 ZWPWUVNMFVVHHE-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Fats And Perfumes (AREA)
- Colloid Chemistry (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、有機液体のゲル化
または固化剤として有用な新規ベンゼンカルボン酸アミ
ド化合物およびこの化合物を有効成分とするゲル化また
は固化剤に関する。本発明のゲル化または固化剤は、塗
料、インク、潤滑油、農業、水産、化粧品や医薬品、繊
維、樹脂、高分子、ゴム、金属等の加工分野を含む産業
分野において利用できる。TECHNICAL FIELD The present invention relates to a novel benzenecarboxylic acid amide compound useful as a gelling or solidifying agent for an organic liquid, and a gelling or solidifying agent containing this compound as an active ingredient. The gelling or solidifying agent of the present invention can be used in industrial fields including coatings, inks, lubricating oils, agriculture, fisheries, cosmetics and pharmaceuticals, fibers, resins, polymers, rubbers, metals and the like.
【0002】[0002]
【従来の技術】一般に前記産業分野において使用される
有機液体類(動植物油脂、エステル、ポリオール、エー
テル、アルコール、炭化水素等)をゲル化または固化す
る機能を有するものとして、12−ヒドロキシステアリ
ン酸、ジベンジリデンソルビトール、脂肪酸のアルカリ
金属塩およびアルカリ土類金属塩等が知られている。2. Description of the Related Art In general, 12-hydroxystearic acid, which has a function of gelling or solidifying organic liquids (animal and vegetable oils, esters, polyols, ethers, alcohols, hydrocarbons, etc.) used in the above-mentioned industrial fields, includes: Dibenzylidene sorbitol, alkali metal salts and alkaline earth metal salts of fatty acids and the like are known.
【0003】この中で、12−ヒドロキシステアリン酸
は安価であるが、ゲル化または固化できる有機液体の種
類が少なく、また得られたゲルが軟化する温度も低い。
一方、ジベンジリデンソルビトールは少量の添加で強い
ゲルを形成するものの、ベンズアルデヒドを遊離すると
いう難点をもち、また、高融点であるため低沸点の短鎖
アルコール類等を固形化するには不適当である。脂肪酸
のアルカリ金属塩・アルカリ土類金属塩は、ゲル化また
は固化のための添加量を多く必要とし、使用可能な条件
も限られる等の制約がある。[0003] Among them, 12-hydroxystearic acid is inexpensive, but there are few kinds of organic liquids that can be gelled or solidified, and the temperature at which the obtained gel softens is low.
On the other hand, dibenzylidene sorbitol forms a strong gel with a small amount of addition, but has the disadvantage of liberating benzaldehyde, and is unsuitable for solidifying low-boiling short-chain alcohols due to its high melting point. is there. Alkali metal salts and alkaline earth metal salts of fatty acids require a large amount of addition for gelation or solidification, and have limitations such as limited usable conditions.
【0004】[0004]
【発明が解決しようとする課題】このように、これまで
提案されているゲル化または固化剤は、前記いずれかの
点で充分に満足できる機能を有するものではなかった。As described above, the gelling or solidifying agents proposed so far do not have a sufficiently satisfactory function in any of the above points.
【0005】従って、本発明の目的は、容易に製造する
ことが可能であり、種々の有機液体を少量の添加でゲル
化または固化でき、均一で、かつ長期間の保存および温
度変化に対して安定性が高いゲル化物または固化物とな
すことができる、有機液体のゲル化または固化剤として
有用なベンゼンカルボン酸アミド化合物およびこの化合
物を有効成分とする有機液体のゲル化または固化剤を提
供することにある。[0005] Accordingly, an object of the present invention is to make it easy to produce, to be able to gel or solidify various organic liquids with a small amount of addition, to be uniform and to have a long term storage and temperature change. Provided are a benzenecarboxylic acid amide compound useful as a gelling or solidifying agent for an organic liquid and a gelling or solidifying agent for an organic liquid containing the compound as an active ingredient, which can be formed into a gelled or solidified product having high stability. It is in.
【0006】[0006]
【課題を解決するための手段】本発明者らは、前記目的
を達成するために鋭意検討を重ねた結果、新規ベンゼン
カルボン酸アミド化合物を合成し、これが種々の有機液
体に対して優れたゲル化能を有することを見出し、本発
明を完成するに至った。Means for Solving the Problems The present inventors have conducted intensive studies to achieve the above object, and as a result, have synthesized a novel benzenecarboxylic acid amide compound, which is an excellent gel for various organic liquids. The inventors have found that the present invention has a chemical ability, and have completed the present invention.
【0007】すなわち本発明は、下記一般式(I)That is, the present invention provides a compound represented by the following general formula (I):
【化5】 Embedded image
【0008】(一般式(I)中、X1 およびX2 は、そ
れぞれ−AA−NHRを表し、AAはアミノ酸アシル
基、各Rは炭素数8〜22のアルキル基、nは1または
2を表す)で示されるベンゼンカルボン酸アミド化合物
を提供する。また、本発明は、前記一般式(I)で示さ
れるベンゼンカルボン酸アミド化合物を有効成分とする
有機液体のゲル化または固化剤を提供する。(In the general formula (I), X 1 and X 2 each represent —AA-NHR, AA is an amino acid acyl group, R is an alkyl group having 8 to 22 carbon atoms, and n is 1 or 2. Benzenecarboxylic acid amide compound represented by the following formula: Further, the present invention provides a gelling or solidifying agent for an organic liquid, comprising the benzenecarboxylic acid amide compound represented by the general formula (I) as an active ingredient.
【0009】上記一般式(I)において、一般式(I)
中、nは1または2であり、nが1であって、かつCO
X2 がCOX1 に対してオルト位にあるとき、X1およ
びX2 はそれぞれ−AA−NHRを表し、各AAはL−
バリルであり、かつ各Rは炭素数12のアルキル基であ
り得、nが1であって、かつCOX2 がCOX1 に対し
てメタ位にあるとき、X1 およびX2 はそれぞれ−AA
−NHRを表し、各AAはL−バリルまたはL−イソロ
イシルであって、かつ各Rは炭素数12のアルキル基で
あるか、または各AAはL−バリルまたはD,L−バリ
ルであって、かつ各Rは炭素数18のアルキル基であり
得、nが1であって、かつCOX2 がCOX1 に対して
パラ位にあるとき、X1 およびX2 はそれぞれ−AA−
NHRを表し、各AAはL−バリル、グリシル、L−ロ
イシルまたはL−イソロイシルであって、かつ各Rは炭
素数12のアルキル基であるか、または各AAはL−バ
リル、L−ロイシル、L−イソロイシルまたはD,L−
バリルであって、かつ各Rは炭素数18のアルキル基で
あり得、nが2のとき、2つのCOX2 はCOX1 に対
して共にメタ位にあり、X1 およびX2 はそれぞれ−A
A−NHRを表し、各AAはL−バリルまたはL−ロイ
シルであって、かつ各Rは炭素数12のアルキル基であ
り得る。In the above general formula (I), the general formula (I)
Wherein n is 1 or 2; n is 1;
When X 2 is in the ortho position relative to COX 1, X 1 and X 2 each represent a -AA-NHR, each AA is L-
X 1 and X 2 are each -AA when n is 1 and COX 2 is meta to COX 1 , and each R may be an alkyl group having 12 carbon atoms.
Represents -NHR, each AA is L-valyl or L-isoleucyl, and each R is an alkyl group having 12 carbon atoms, or each AA is L-valyl or D, L-valyl, And each R can be an alkyl group having 18 carbon atoms, when n is 1 and COX 2 is in the para position with respect to COX 1 , X 1 and X 2 are each -AA-
Represents NHR, each AA is L-valyl, glycyl, L-leucyl or L-isoleucyl, and each R is an alkyl group having 12 carbon atoms, or each AA is L-valyl, L-leucyl, L-isoleucyl or D, L-
Valyl, and each R may be an alkyl group having 18 carbon atoms, and when n is 2, the two COX 2 are both meta to COX 1 , and X 1 and X 2 are each -A
Represents A-NHR, wherein each AA is L-valyl or L-leucyl, and each R may be an alkyl group having 12 carbon atoms.
【0010】[0010]
【発明の実施の形態】本発明のベンゼンカルボン酸アミ
ド化合物は、前記一般式(I)で示される。一般式
(I)中、X1 およびX2 は、それぞれ−AA−NHR
を表し、AAはアミノ酸アシル基、各Rは炭素数8〜2
2のアルキル基、nは1または2を表す。ベンゼン環に
直結するカルボニル基と−AA−との結合−COAA−
はアミド結合である。BEST MODE FOR CARRYING OUT THE INVENTION The benzenecarboxylic acid amide compound of the present invention is represented by the above general formula (I). In the general formula (I), X 1 and X 2 each represent -AA-NHR
AA represents an amino acid acyl group, and each R has 8 to 2 carbon atoms.
2 alkyl groups, n represents 1 or 2. A bond between a carbonyl group directly bonded to a benzene ring and -AA- -COAA-
Is an amide bond.
【0011】アミノ酸アシル基(AA)は、具体的に、
グリシル、アラニル、バリル、ロイシル、イソロイシル
等をあげることができ、このうちゲル化能の点で特に好
ましいのはバリルである。なおこれらのアミノ酸アシル
基はL体、DL体共用いることが可能であり、アミノ酸
アシル基自身は単独で使用してもよく、あるいは2種以
上を混合して用いてもよい。The amino acid acyl group (AA) is specifically represented by
Examples thereof include glycyl, alanyl, valyl, leucyl, isoleucyl and the like, and among them, valyl is particularly preferred in terms of gelling ability. These amino acid acyl groups can be used in both L-form and DL-form. The amino acid acyl groups themselves may be used alone or in combination of two or more.
【0012】また、アルキル基(R)は炭素数が8〜2
2で、飽和の、直鎖状および/または分岐状アルキル基
が使用可能である。具体的に直鎖状アルキル基として、
オクチル基、ノニル基、デシル基、ウンデシル基、ドデ
シル基、トリデシル基、テトラデシル基、ペンタデシル
基、ヘキサデシル基、ヘプタデシル基、オクタデシル
基、ノナデシル基、イコシル基、ヘンイコシル基、ドコ
シル基を例示することができる。また分岐状アルキル基
として、2−エチルヘキシル基、2,4,4−トリメチ
ルペンチル基、3,5,5−トリメチルヘキシル基、
3,7−ジメチルオクチル基、6−プロピルノニル基、
12−メチルトリデシル基、2−メチルテトラデシル
基、5−メチルテトラデシル基、2,2−ジメチルテト
ラデシル基、2−ヘキシルデシル基、2−ヘプチルウン
デシル基、2−オクチルドデシル基等を例示できる。こ
れらの直鎖状アルキル基または分岐状アルキル基は単独
で使用してもよく、あるいは2種以上を混合して用いて
もよい。ゲル化能の点で好ましいのは、ドデシル基(炭
素数12の直鎖状アルキル基)およびオクタデシル基
(炭素数18の直鎖状アルキル基)である。その中でも
オクタデシル基が特に好ましい。The alkyl group (R) has 8 to 2 carbon atoms.
2, saturated, straight-chain and / or branched alkyl groups can be used. Specifically as a linear alkyl group,
Octyl group, nonyl group, decyl group, undecyl group, dodecyl group, tridecyl group, tetradecyl group, pentadecyl group, hexadecyl group, heptadecyl group, octadecyl group, nonadecyl group, icosyl group, henycosyl group, docosyl group can be exemplified. . As a branched alkyl group, a 2-ethylhexyl group, a 2,4,4-trimethylpentyl group, a 3,5,5-trimethylhexyl group,
3,7-dimethyloctyl group, 6-propylnonyl group,
12-methyltridecyl, 2-methyltetradecyl, 5-methyltetradecyl, 2,2-dimethyltetradecyl, 2-hexyldecyl, 2-heptylundecyl, 2-octyldodecyl, etc. Can be illustrated. These linear alkyl groups or branched alkyl groups may be used alone or as a mixture of two or more. Preferred in terms of gelling ability are a dodecyl group (a linear alkyl group having 12 carbon atoms) and an octadecyl group (a linear alkyl group having 18 carbon atoms). Among them, an octadecyl group is particularly preferred.
【0013】また、nは1または2であり、従って基本
骨格をなすベンゼンカルボン酸は、ベンゼンジカルボン
酸であるか、またはベンゼントリカルボン酸である。具
体的には、ベンゼンジカルボン酸としてフタル酸(1,
2−ベンゼンジカルボン酸)、イソフタル酸(1,3−
ベンゼンジカルボン酸)、テレフタル酸(1,4−ベン
ゼンジカルボン酸)、およびベンゼントリカルボン酸と
して1,3,5−トリカルボン酸、1,2,4−ベンゼ
ントリカルボン酸等を挙げることができる。このうちゲ
ル化能の点で特に好ましいのは、ベンゼンジカルボン酸
ではテレフタル酸であり、ベンゼントリカルボン酸では
1,3,5−ベンゼントリカルボン酸である。[0013] Further, n is 1 or 2, and accordingly, the benzenecarboxylic acid constituting the basic skeleton is benzenedicarboxylic acid or benzenetricarboxylic acid. Specifically, phthalic acid (1, 1) is used as benzenedicarboxylic acid.
2-benzenedicarboxylic acid), isophthalic acid (1,3-
Benzenedicarboxylic acid), terephthalic acid (1,4-benzenedicarboxylic acid), and benzenetricarboxylic acid include 1,3,5-tricarboxylic acid, 1,2,4-benzenetricarboxylic acid and the like. Of these, terephthalic acid is particularly preferred for benzenedicarboxylic acid and 1,3,5-benzenetricarboxylic acid is preferred for benzenetricarboxylic acid in terms of gelling ability.
【0014】本発明のベンゼンカルボン酸アミド化合物
の具体例54種の化合物を以下列挙する。なお、別段の
指摘がない限り、各アミノ酸アシル基AAは同じであ
り、かつRも同じである。また、X1 =X2 の場合、こ
れらを一括してXで表示する。Specific examples of the benzenecarboxylic acid amide compounds of the present invention 54 compounds are listed below. Unless otherwise specified, each amino acid acyl group AA is the same, and R is also the same. When X 1 = X 2 , these are collectively displayed as X.
【0015】前記一般式(I)中、nが1であって、か
つCOX2 がCOX1 に対してオルト位にあるフタル酸
ジアミド化合物として、アミノ酸アシル基(以下AAと
する)がL−バリルであり、かつアルキル基(以下Rと
する)がドデシル基(X=L−Val −NH−C12H25)
である化合物1:N,N’−フタロイル−ビス(L−バ
リルアミノドデカン)、AAがL−イソロイシルであ
り、かつRがドデシル基(X=L−Ile −NH−C12H
25)である化合物2:N,N’−フタロイル−ビス(L
−イソロイシルアミノドデカン)、AAがL−バリルで
あり、かつRがオクタデシル基(X=L−Val −NH−
C18H37)である化合物3:N,N’−フタロイル−ビ
ス(L−バリルアミノオクタデカン)、AAがL−ロイ
シルであり、かつRがドコシル基(X=L−Leu −NH
−C22H45)である化合物4:N,N’−フタロイル−
ビス(L−ロイシルアミノドコサン)、AAがL−アラ
ニルであり、かつRがヘキサデシル基(X=L−Ala −
NH−C16H33)である化合物5:N,N’−フタロイ
ル−ビス(L−アラニルアミノヘキサデカン)、AAが
グリシルであり、かつRがオクタデシル基(X=L−Gl
y −NH−C18H37)である化合物6:N,N’−フタ
ロイル−ビス(グリシルアミノオクタデカン)、AAが
D,L−ロイシルであり、かつRがテトラデシル基(X
=D,L−Leu−NH−C14H29)である化合物7:
N,N’−フタロイル−ビス(D,L−ロイシルアミノ
テトラデカン)、AAがL−バリルであり、かつRが2
−エチルヘキシル基(X=L−Val −NH−C8 H17)
である化合物8:N,N’−フタロイル−ビス(L−バ
リルアミノ−2−エチルヘキサン)、AAがL−イソロ
イシルであり、かつRの一方がドデシル基であり他方が
オクタデシル基(X1 =L−Ile −NH−C12H25、X
2 =L−Ile −NH−C18H37)である化合物9、AA
の一方がL−イソロイシルであり他方がL−ロイシルで
あり、かつRがドデシル基(X1 =L−Ile −NH−C
12H25、X2 =L−Leu −NH−C12H25)である化合
物10が挙げられる。In the above general formula (I), the phthalic diamide compound wherein n is 1 and COX 2 is ortho to COX 1 is an amino acid acyl group (hereinafter referred to as AA) L-valyl. , and the and (or less R) alkyl group is dodecyl (X = L-Val -NH- C 12 H 25)
In a compound 1: N, N'-phthaloyl - bis (L- valyl aminododecanoic), AA is L- isoleucyl, and R is a dodecyl group (X = L-Ile -NH- C 12 H
25 ) Compound 2: N, N'-phthaloyl-bis (L
-Isoleucylaminododecane), AA is L-valyl, and R is an octadecyl group (X = L-Val-NH-
Compound 3: C 18 H 37 ): N, N′-phthaloyl-bis (L-valylaminooctadecane), AA is L-leucyl, and R is a docosyl group (X = L-Leu-NH)
-C 22 H 45), compound 4: N, N'-phthaloyl -
Bis (L-leucylaminodocosan), AA is L-alanyl, and R is a hexadecyl group (X = L-Ala −
NH-C 16 H 33), Compound 5: N, N'-phthaloyl - bis (L- alanyl-amino hexadecanoic), AA is glycyl, and R is octadecyl (X = L-Gl
y—NH—C 18 H 37 ) Compound 6: N, N′-phthaloyl-bis (glycylaminooctadecane), AA is D, L-leucyl, and R is a tetradecyl group (X
= D, L-Leu-NH -C 14 H 29) , compound 7:
N, N'-phthaloyl-bis (D, L-leucylaminotetradecane), AA is L-valyl, and R is 2
- ethylhexyl group (X = L-Val -NH- C 8 H 17)
8: N, N′-phthaloyl-bis (L-valylamino-2-ethylhexane), AA is L-isoleucyl, and one of R is a dodecyl group and the other is an octadecyl group (X 1 = L -Ile -NH-C 12 H 25, X
2 = L-Ile -NH-C 18 H 37) , compound 9, AA
Is L-isoleucyl and the other is L-leucyl, and R is a dodecyl group (X 1 = L-Ile-NH-C
12 H 25 , X 2 = L-Leu-NH—C 12 H 25 ).
【0016】上記一般式(I)中、nが1であって、か
つCOX2 がCOX1 に対してメタ位にあるイソフタル
酸ジアミド化合物として、AAがL−バリルであり、か
つRがドデシル基(X=L−Val −NH−C12H25)で
ある化合物11:N,N’−イソフタロイル−ビス(L
−バリルアミノドデカン)、AAがL−イソロイシルで
あり、かつRがドデシル基(X=L−Ile −NH−C12
H25)である化合物12:N,N’−イソフタロイル−
ビス(L−イソロイシルアミノドデカン)、AAがL−
バリルであり、かつRがオクタデシル基(X=L−Val
−NH−C18H37)である化合物13:N,N’−イソ
フタロイル−ビス(L−バリルアミノオクタデカン)、
AAがD,L−バリルであり、かつRがオクタデシル基
(X=D,L−Val −NH−C18H37)である化合物1
4:N,N’−イソフタロイル−ビス(D,L−バリル
アミノオクタデカン)、AAがL−ロイシルであり、か
つRがオクタドコシル基(X=L−Leu −NH−C22H
45)である化合物15:N,N’−イソフタロイル−ビ
ス(L−ロイシルアミノオクタドコサン)、AAがL−
アラニルであり、かつRがヘキサデシル基(X=L−Al
a −NH−C16H33)である化合物16:N,N’−イ
ソフタロイル−ビス(L−アラニルアミノヘキサデカ
ン)、AAがグリシルであり、かつRがオクタデシル基
(X=Gly −NH−C18H37)である化合物17:N,
N’−イソフタロイル−ビス(グリシルアミノオクタデ
カン)、AAがD,L−ロイシルであり、かつRがテト
ラデシル基(X=D,L−Leu−NH−C14H29)であ
る化合物18:N,N’−イソフタロイル−ビス(D,
L−ロイシルアミノテトラデカン)、AAがL−バリル
であり、かつRが2−エチルヘキシル基(X=L−Val
−NH−C8 H17)である化合物19:N,N’−イソ
フタロイル−ビス(L−バリルアミノ−2−エチルヘキ
サン)、AAがL−イソロイシルであり、かつRの一方
がドデシル基であり他方がオクタデシル基(X1 =L−
Ile −NH−C12H25、X2 =L−Ile −NH−C18H
37)である化合物20、AAの一方がL−イソロイシル
であり他方がL−ロイシルであり、かつRがドデシル基
(X1 =L−Ile −NH−C12H25、X2 =L−Leu −
NH−C12H25)である化合物21が挙げられる。In the above general formula (I), as an isophthalic diamide compound wherein n is 1 and COX 2 is meta-position to COX 1 , AA is L-valyl and R is a dodecyl group (X = L-Val -NH- C 12 H 25) , compound 11: N, N'isophthaloyl - bis (L
- valyl aminododecanoic), AA is L- isoleucyl, and R is a dodecyl group (X = L-Ile -NH- C 12
H 25), Compound 12: N, N'isophthaloyl -
Bis (L-isoleucylaminododecane), AA is L-
Valyl and R is an octadecyl group (X = L-Val
-NH-C 18 H 37), Compound 13: N, N'isophthaloyl - bis (L- valyl amino octadecane),
AA is D, L-a-valyl, and the compound R is an octadecyl group (X = D, L-Val -NH-C 18 H 37) 1
4: N, N'isophthaloyl - bis (D, L- valyl amino-octadecane), AA is L- leucyl and R is Okutadokoshiru group (X = L-Leu -NH- C 22 H
45 ), compound 15: N, N'-isophthaloyl-bis (L-leucylaminooctadocosan), wherein AA is L-
Alanyl, and R is a hexadecyl group (X = L-Al
a -NH-C 16 H 33), Compound 16: N, N'isophthaloyl - bis (L- alanyl-amino hexadecanoic), AA is glycyl, and R is octadecyl (X = Gly -NH-C 18 H 37 )
N'- isophthaloyl - bis (glycyl-aminooctadecane), AA is D, an L- leucyl and R is a tetradecyl radical (X = D, L-Leu -NH-C 14 H 29) Compound 18: N , N'-isophthaloyl-bis (D,
L-leucylaminotetradecane), AA is L-valyl, and R is a 2-ethylhexyl group (X = L-Val
—NH—C 8 H 17 ) compound 19: N, N′-isophthaloyl-bis (L-valylamino-2-ethylhexane), AA is L-isoleucyl, and one of R is a dodecyl group and the other is Is an octadecyl group (X 1 = L-
Ile -NH-C 12 H 25, X 2 = L-Ile -NH-C 18 H
37) compounds wherein 20, one of AA is L- isoleucyl other is L- leucyl and R is a dodecyl group (X 1 = L-Ile -NH -C 12 H 25, X 2 = L-Leu −
NH-C 12 H 25), compound 21 can be mentioned.
【0017】上記一般式(I)中、nが1であって、か
つCOX2 がCOX1 に対してパラ位にあるテレフタル
酸ジアミド化合物として、AAがL−バリルであり、か
つRがドデシル基(X=L−Val −NH−C12H25)で
ある化合物22:N,N’−テレフタロイル−ビス(L
−バリルアミノドデカン)、AAがグリシルであり、か
つRがドデシル基(X=Gly −NH−C12H25)である
化合物23:N,N’−テレフタロイル−ビス(グリシ
ルアミノドデカン)、AAがL−ロイシルであり、かつ
Rがドデシル基(X=L−Leu −NH−C12H25)であ
る化合物24:N,N’−テレフタロイル−ビス(L−
ロイシルアミノドデカン)、AAがL−イソロイシルで
あり、かつRがドデシル基(X=L−Ile −NH−C12
H25)である化合物25:N,N’−テレフタロイル−
ビス(L−イソロイシルアミノドデカン)、AAがL−
バリルであり、かつRがオクタデシル基(X=L−Val
−NH−C18H37)である化合物26:N,N’−テレ
フタロイル−ビス(L−バリルアミノオクタデカン)、
AAがL−ロイシルであり、かつRがオクタデシル基
(X=L−Leu −NH−C18H37)である化合物27:
N,N’−テレフタロイル−ビス(L−ロイシルアミノ
オクタデカン)、AAがL−イソロイシルであり、かつ
Rがオクタデシル基(X=L−Ile −NH−C18H37)
である化合物28:N,N’−テレフタロイル−ビス
(L−イソロイシルアミノオクタデカン)、AAがD,
L−バリルであり、かつRがオクタデシル基(X=D,
L−Val −NH−C18H37)である化合物29:N,
N’−テレフタロイル−ビス(D,L−バリルアミノオ
クタデカン)、AAがL−バリルであり、かつRがテト
ラデシル基(X=L−Val −NH−C14H29)である化
合物30:N,N’−テレフタロイル−ビス(L−バリ
ルアミノテトラデカン)、AAがL−バリルであり、か
つRがヘキサデシル基(X=L−Val −NH−C
16H33)である化合物31:N,N’−テレフタロイル
−ビス(L−バリルアミノヘキサデカン)、AAがL−
バリルであり、かつRがイコシル基(X=L−Val −N
H−C20H41)である化合物32:N,N’−テレフタ
ロイル−ビス(L−バリルアミノイコサン)、AAがL
−バリルであり、かつRがドコシル基(X=L−Val −
NH−C22H45)である化合物33:N,N’−テレフ
タロイル−ビス(L−バリルアミノドコサン)、AAが
L−ロイシルであり、かつRがオクタドコシル基(X=
L−Leu −NH−C22H45)である化合物34:N,
N’−テレフタロイル−ビス(L−ロイシルアミノオク
タドコサン)、AAがL−アラニルであり、かつRがヘ
キサデシル基(X=L−Ala −NH−C16H33)である
化合物35:N,N’−テレフタロイル−ビス(L−ア
ラニルアミノヘキサデカン)、AAがグリシルであり、
かつRがオクタデシル基(X=Gly −NH−C18H37)
である化合物36:N,N’−テレフタロイル−ビス
(グリシルアミノオクタデカン)、AAがD,L−ロイ
シルであり、かつRがテトラデシル基(X=D,L−Le
u−NH−C14H29)である化合物37:N,N’−テ
レフタロイル−ビス(D,L−ロイシルアミノテトラデ
カン)、AAがL−バリルであり、かつRが2−エチル
ヘキシル基(X=L−Val −NH−C8 H17)である化
合物38:N,N’−テレフタロイル−ビス(L−バリ
ルアミノ−2−エチルヘキサン)、AAがL−イソロイ
シルであり、かつRの一方がドデシル基であり他方がオ
クタデシル基(X1 =L−Ile −NH−C12H25、X2
=L−Ile −NH−C18H37)である化合物39、AA
の一方がL−イソロイシルであり他方がL−ロイシルで
あり、かつRがドデシル基(X1 =L−Ile −NH−C
12H25、X2 =L−Leu −NH−C12H25)である化合
物40が挙げられる。In the above general formula (I), as a terephthalic acid diamide compound wherein n is 1 and COX 2 is para to COX 1 , AA is L-valyl and R is a dodecyl group (X = L-Val -NH- C 12 H 25) , compound 22: N, N'terephthaloyl - bis (L
- valyl aminododecanoic), AA is glycyl, and compounds wherein R is a dodecyl group (X = Gly -NH-C 12 H 25) 23: N, N'- terephthaloyl - bis (glycyl aminododecanoic), AA There L- is leucyl and compound R is a dodecyl group (X = L-Leu -NH- C 12 H 25) 24: N, N'- terephthaloyl - bis (L-
Isoleucyl aminododecanoic), AA is L- isoleucyl, and R is a dodecyl group (X = L-Ile -NH- C 12
H 25 ) Compound 25: N, N′-terephthaloyl-
Bis (L-isoleucylaminododecane), AA is L-
Valyl and R is an octadecyl group (X = L-Val
-NH-C 18 H 37), Compound 26: N, N'terephthaloyl - bis (L- valyl amino octadecane),
AA is L- leucyl and R is octadecyl (X = L-Leu -NH- C 18 H 37) Compound 27:
N, N'terephthaloyl - bis (L- leucyl amino-octadecane), AA is L- isoleucyl, and R is octadecyl (X = L-Ile -NH- C 18 H 37)
28: N, N′-terephthaloyl-bis (L-isoleucylaminooctadecane), wherein AA is D,
L-valyl and R is an octadecyl group (X = D,
L-Val -NH-C 18 H 37) , Compound 29: N,
N'- terephthaloyl - bis (D, L- valyl amino-octadecane), AA is L- valyl, and compounds wherein R is a tetradecyl radical (X = L-Val -NH- C 14 H 29) 30: N, N'-terephthaloyl-bis (L-valylaminotetradecane), AA is L-valyl, and R is a hexadecyl group (X = L-Val-NH-C
16 H 33), Compound 31: N, N'terephthaloyl - bis (L- valyl amino-hexadecane), AA is L-
Valyl and R is an icosyl group (X = L-Val-N
Compound 32 which is H—C 20 H 41 ): N, N′-terephthaloyl-bis (L-valylaminoicosane), and AA is L
-Valyl, and R is a docosyl group (X = L-Val-
Compound 33 which is NH—C 22 H 45 ): N, N′-terephthaloyl-bis (L-valylaminodocosan), AA is L-leucyl, and R is an octadocosyl group (X =
L-Leu -NH-C 22 H 45) , Compound 34: N,
N'- terephthaloyl - bis (L- leucyl amino oct docosanoic), an AA is L- alanyl, and compounds wherein R is a hexadecyl group (X = L-Ala -NH- C 16 H 33) 35: N , N′-terephthaloyl-bis (L-alanylaminohexadecane), AA is glycyl,
And R is octadecyl (X = Gly -NH-C 18 H 37)
36: N, N′-terephthaloyl-bis (glycylaminooctadecane), AA is D, L-leucyl, and R is a tetradecyl group (X = D, L-Le)
u-NH-C 14 H 29 ) , Compound 37: N, N'terephthaloyl - bis (D, L- leucyl amino tetradecane), a AA is L- valyl, and wherein R is 2-ethylhexyl group (X = L-Val -NH-C 8 H 17) , compound 38: N, N'terephthaloyl - bis (L- Bariruamino 2-ethyl hexane), AA is L- isoleucyl, and one of R is dodecyl The other being an octadecyl group (X 1 = L-Ile-NH—C 12 H 25 , X 2
= L-Ile -NH-C 18 H 37) , compound 39, AA
Is L-isoleucyl and the other is L-leucyl, and R is a dodecyl group (X 1 = L-Ile-NH-C
12 H 25 , X 2 = L-Leu-NH—C 12 H 25 ).
【0018】上記一般式(I)中、nが2であって、か
つ2つのCOX2 がCOX1 に対して共にメタ位にある
1,3,5−トリカルボン酸トリアミド化合物として、
AAがL−バリルであり、かつRがドデシル基(X=L
−Val −NH−C12H25)である化合物41:N,
N’,N”−1,3,5−ベンゼントリカルボニル−ト
リス(L−バリルアミノドデカン)、AAがL−ロイシ
ルであり、かつRがドデシル基(X=L−Leu −NH−
C12H25)である化合物42:N,N’,N”−1,
3,5−ベンゼントリカルボニル−トリス(L−ロイシ
ルアミノドデカン)、AAがL−イソロイシルであり、
かつRがドデシル基(X=L−Ile −NH−C12H25)
である化合物43:N,N’,N”−1,3,5−ベン
ゼントリカルボニル−トリス(L−イソロイシルアミノ
ドデカン)、AAがL−バリルであり、かつRがオクタ
デシル基(X=L−Val −NH−C18H37)である化合
物44:N,N’,N”−1,3,5−ベンゼントリカ
ルボニル−トリス(L−バリルアミノオクタデカン)、
AAがL−ロイシルであり、かつRがオクタドコシル基
(X=L−Leu −NH−C22H45)である化合物45:
N,N’,N”−1,3,5−ベンゼントリカルボニル
−トリス(L−ロイシルアミノオクタドコサン)、AA
がL−アラニルであり、かつRがヘキサデシル基(X=
L−Ala −NH−C16H33)である化合物46:N,
N’,N”−1,3,5−ベンゼントリカルボニル−ト
リス(L−アラニルアミノヘキサデカン)、AAがグリ
シルであり、かつRがオクタデシル基(X=Gly −NH
−C18H37)である化合物47:N,N’,N”−1,
3,5−ベンゼントリカルボニル−トリス(グリシルア
ミノオクタデカン)、AAがD,L−ロイシルであり、
かつRがテトラデシル基(X=D,L−Leu−NH−C
14H29)である化合物48:N,N’,N”−1,3,
5−ベンゼントリカルボニル−トリス(D,L−ロイシ
ルアミノテトラデカン)、AAがL−バリルであり、か
つRが2−エチルヘキシル基(X=L−Val −NH−C
8 H17)である化合物49:N,N’,N”−1,3,
5−ベンゼントリカルボニル−トリス(L−バリルアミ
ノ−2−エチルヘキサン)、AAがL−イソロイシルで
あり、かつ3つのRのうち1つがドデシル基であり他2
つがオクタデシル基(X1 =L−Ile −NH−C
12H25、X2 =L−Ile −NH−C18H37)である化合
物50、AAがL−イソロイシルであり、3つのRのう
ち1つがオクタデシル基であり他2つがドデシル基(X
1 =L−Ile −NH−C18H37、X2 =L−Ile −NH
−C12H25)である化合物51、3つのAAのうち1つ
がL−イソロイシルであり他2つがL−ロイシルであ
り、かつRがドデシル基(X1 =L−Ile −NH−C12
H25、X2 =L−Leu −NH−C12H25)である化合物
52、3つのAAのうち1つがL−ロイシルであり他2
つがL−イソロイシルであり、かつRがドデシル基(X
1 =L−Leu −NH−C12H25、X2 =L−Ile −NH
−C12H25)である化合物53が挙げられる。In the general formula (I), n is 2 and two COX 2 are both meta-positions to COX 1 as a 1,3,5-tricarboxylic acid triamide compound,
AA is L-valyl, and R is a dodecyl group (X = L
-Val -NH-C 12 H 25), Compound 41: N,
N ', N "-1,3,5-benzenetricarbonyl-tris (L-valylaminododecane), AA is L-leucyl, and R is a dodecyl group (X = L-Leu-NH-
Compound 42 which is C 12 H 25 ): N, N ′, N ″ -1,
3,5-benzenetricarbonyl-tris (L-leucylaminododecane), AA is L-isoleucyl,
And R is a dodecyl group (X = L-Ile -NH- C 12 H 25)
Compound 43: N, N ′, N ″ -1,3,5-benzenetricarbonyl-tris (L-isoleucylaminododecane), AA is L-valyl, and R is an octadecyl group (X = L-Val -NH-C 18 H 37) , compound 44: N, N ', N "-1,3,5- benzene tricarbonyl - tris (L- valyl amino octadecane),
AA is L- leucyl, and compound R is an Okutadokoshiru group (X = L-Leu -NH- C 22 H 45) 45:
N, N ', N "-1,3,5-benzenetricarbonyl-tris (L-leucylaminooctadocosan), AA
Is L-alanyl, and R is a hexadecyl group (X =
L-Ala -NH-C 16 H 33) , Compound 46: N,
N ', N "-1,3,5-benzenetricarbonyl-tris (L-alanylaminohexadecane), AA is glycyl, and R is an octadecyl group (X = Gly-NH
-C 18 H 37 ), compound 47: N, N ′, N ″ -1,
3,5-benzenetricarbonyl-tris (glycylaminooctadecane), AA is D, L-leucyl,
And R is a tetradecyl group (X = D, L-Leu-NH-C
14 H 29 ) Compound 48: N, N ′, N ″ -1,3,
5-benzenetricarbonyl-tris (D, L-leucylaminotetradecane), AA is L-valyl, and R is a 2-ethylhexyl group (X = L-Val-NH-C
8 H 17), Compound 49: N, N ', N "-1,3,
5-benzenetricarbonyl-tris (L-valylamino-2-ethylhexane), AA is L-isoleucyl, and one of the three Rs is a dodecyl group and the other 2
One is an octadecyl group (X 1 = L-Ile-NH-C
12 H 25, X 2 = L -Ile -NH-C 18 H 37) , compound 50, AA is the L- isoleucyl, three one of R is an octadecyl group other two are dodecyl (X
1 = L-Ile -NH-C 18 H 37, X 2 = L-Ile -NH
-C 12 H 25 ), one of the three AAs is L-isoleucyl, the other two are L-leucyl, and R is a dodecyl group (X 1 = L-Ile-NH-C 12).
H 25, X 2 = L- Leu -NH-C 12 H 25) one of the compounds 52,3 single AA where it is L- leucyl other 2
One is L-isoleucyl and R is a dodecyl group (X
1 = L-Leu -NH-C 12 H 25, X 2 = L-Ile -NH
—C 12 H 25 ).
【0019】上記一般式(I)中、nが2であって、か
つ2つのCOX2 がCOX1 に対して一方がオルト位に
あり、他方がパラ位にある1,2,4−トリカルボン酸
トリアミド化合物として、AAがL−バリルであり、か
つRがオクタデシル基(X=L−Val −NH−C
18H37)である化合物54:N,N’,N”−1,2,
4−ベンゼントリカルボニル−トリス(L−バリルアミ
ノオクタデカン)が挙げられる。In the above general formula (I), 1,2,4-tricarboxylic acid wherein n is 2 and two COX 2 are in the ortho position with respect to COX 1 and the other is in the para position As a triamide compound, AA is L-valyl and R is an octadecyl group (X = L-Val-NH-C
18 H 37 ) Compound 54: N, N ′, N ″ -1,2,2
4-benzenetricarbonyl-tris (L-valylaminooctadecane).
【0020】これらベンゼンカルボン酸アミド化合物の
なかで、化合物26(N,N’−テレフタロイル−ビス
(L−バリルアミノオクタデカン))が最も多種の有機
溶媒をゲル化できる優れたゲル化剤である。Among these benzenecarboxylic acid amide compounds, compound 26 (N, N'-terephthaloyl-bis (L-valylaminooctadecane)) is an excellent gelling agent capable of gelling most kinds of organic solvents.
【0021】本発明のベンゼンカルボン酸アミド化合物
は、次の二段階の反応で容易に合成することができる。The benzenecarboxylic acid amide compound of the present invention can be easily synthesized by the following two-step reaction.
【0022】[0022]
【化6】 Embedded image
【0023】まず段階(1)において、一般式(I)に
おけるアミノ酸アシル基AAに対応するアミノ酸H−A
A−OHとアルキルアミンRNH2 (Rは前記定義の通
り)から従来公知の方法を用いてアミノ酸アルキルアミ
ドH−AA−NHRを容易に合成することができる。そ
の方法や条件は特に限定されないが、例えばアミノ酸の
N末端をベンジルオキシカルボニル基等の保護基で保護
しておき、続いて両原料を所定の反応当量で乾燥溶剤中
で脱水反応を行った後、生成物の保護基を除去して所望
のアミノ酸アルキルアミドを得ることができる。この反
応は、両反応原料をほぼ等モル量用い、0℃ないし10
0℃の温度で15時間ないし30時間行うことができ
る。First, in step (1), the amino acid HA corresponding to the amino acid acyl group AA in the general formula (I)
A-OH with an alkylamine RNH 2 (R is the as defined) can be easily synthesized amino acid alkyl amide H-AA-NHR by a known method from. Although the method and conditions are not particularly limited, for example, the N-terminal of an amino acid is protected with a protecting group such as a benzyloxycarbonyl group, and then both materials are subjected to a dehydration reaction in a dry solvent at a predetermined reaction equivalent. The desired amino acid alkylamide can be obtained by removing the protecting group of the product. In this reaction, both reaction materials are used in approximately equimolar amounts,
The reaction can be performed at a temperature of 0 ° C. for 15 to 30 hours.
【0024】次に段階(2)において、得られたアミノ
酸アルキルアミドに対して式(II)で示されるベンゼン
カルボン酸クロライドを反応させ、従来公知の方法を用
いて容易にベンゼンカルボン酸アミド化合物(式
(I))とすることができる。その方法や条件は特に限
定されないが、例えばアミノ酸アルキルアミドと、ベン
ゼンカルボン酸クロライドとを所定の反応当量でトリエ
チルアミン等の塩基の存在下、乾燥溶媒中で縮合反応せ
しめればよい。この反応は、両反応原料をモル比ほぼ
(n+1):1で用い、0℃ないし100℃の温度で5
時間ないし15時間行うことができる。Next, in step (2), the obtained amino acid alkylamide is reacted with a benzenecarboxylic acid chloride represented by the formula (II), and the benzenecarboxylic acid amide compound ( Formula (I)). Although the method and conditions are not particularly limited, for example, an amino acid alkylamide and benzenecarboxylic acid chloride may be subjected to a condensation reaction in a dry solvent in a predetermined reaction equivalent in the presence of a base such as triethylamine. In this reaction, both reactants are used in a molar ratio of approximately (n + 1): 1 at a temperature of 0 ° C. to 100 ° C.
It can be performed for hours to 15 hours.
【0025】反応物中に未反応の原料や副生成物(モノ
アミド化合物等)が残存する場合には減圧留去、溶剤分
別等の公知手段で精製することができる。例えば、反応
物の精製は、減圧下での未反応物等の除去、アセトン等
の多量の有機溶媒による再結晶、活性白土、活性炭、シ
リカゲル、アルミナ等の吸着剤処理、その他により行う
ことができ、必要に応じてこれらを単独でもしくは組み
合わせて適用すればよい。なお、本発明の化合物を有機
液体のゲル化もしくは固化剤として使用する場合は、若
干(数重量%未満)の未反応原料(ベンゼンカルボン酸
および/またはアミノ酸アルキルアミド)やモノアミド
化合物等の副生成物の混在は特にさしつかえない。When unreacted raw materials and by-products (such as monoamide compounds) remain in the reaction product, they can be purified by known means such as distillation under reduced pressure and solvent separation. For example, the purification of the reactants can be performed by removing unreacted substances and the like under reduced pressure, recrystallization with a large amount of an organic solvent such as acetone, activated clay, activated carbon, silica gel, treatment with an adsorbent such as alumina, and the like. These may be applied alone or in combination as needed. When the compound of the present invention is used as a gelling agent or a solidifying agent for an organic liquid, a small amount (less than several weight%) of unreacted raw materials (benzene carboxylic acid and / or amino acid alkylamide) and by-products of monoamide compound and the like may be used. Mixing of things is not particularly noticeable.
【0026】本発明のベンゼンカルボン酸アミド化合物
は、各種有機液体のゲル化または固化剤として有用であ
る。The benzenecarboxylic acid amide compound of the present invention is useful as a gelling or solidifying agent for various organic liquids.
【0027】ここで有機液体としては、大豆油、菜種
油、コーン油、サフラワー油、ヒマワリ油、綿実油、オ
リーブ油、パーム油、ヒマシ油、魚油、豚脂、牛脂等の
動植物油脂類、ミリスチン酸イソプロピル、トリ−2−
エチルヘキサン酸グリセリド、ミリスチン酸2−オクチ
ルドデシル等のエステル類、ポリエチレングリコール、
ポリプロピレングリコール、ポリグリセリン等のポリオ
ール類、エチルセロソルブ、ブチルセロソルブ等のエー
テル類、メタノール、エタノール等のアルコール類、灯
油、重油、流動パラフィン、イソパラフィン等の炭化水
素系油剤、また、キシレン、トルエン等の有機溶剤や廃
食用油、廃潤滑油、廃金属加工油剤等のいわゆる廃油類
を対象とすることができる。The organic liquids include animal and vegetable oils and fats such as soybean oil, rapeseed oil, corn oil, safflower oil, sunflower oil, cottonseed oil, olive oil, palm oil, castor oil, fish oil, lard, tallow, and isopropyl myristate. , Tri-2-
Esters such as ethylhexanoic acid glyceride and 2-octyldodecyl myristate, polyethylene glycol,
Polyols such as polypropylene glycol and polyglycerin, ethers such as ethyl cellosolve and butyl cellosolve, alcohols such as methanol and ethanol, kerosene, heavy oil, liquid oils such as liquid paraffin and isoparaffin, and organic oils such as xylene and toluene So-called waste oils such as solvents, waste edible oils, waste lubricating oils, waste metal processing oils and the like can be targeted.
【0028】本発明においてゲル化または固化剤として
使用するベンゼンジカルボン酸ジアミド化合物は、好ま
しくはベンゼンジカルボン酸ジアミド化合物、あるいは
ベンゼンジカルボン酸ジアミド化合物とベンゼンジカル
ボン酸モノアミド化合物との混合物であり、最も好まし
くはベンゼンジカルボン酸ジアミド化合物である。同様
に、本発明において使用するベンゼントリカルボン酸ト
リアミド化合物は、好ましくはベンゼントリカルボン酸
トリアミド化合物、あるいはベンゼントリカルボン酸ト
リアミド化合物とベンゼントリカルボン酸ジアミド化合
物との混合物であり、最も好ましくはベンゼントリカル
ボン酸トリアミド化合物である。The benzenedicarboxylic acid diamide compound used as a gelling or solidifying agent in the present invention is preferably a benzenedicarboxylic acid diamide compound or a mixture of a benzenedicarboxylic acid diamide compound and a benzenedicarboxylic acid monoamide compound, most preferably. It is a benzenedicarboxylic acid diamide compound. Similarly, the benzenetricarboxylic acid triamide compound used in the present invention is preferably a benzenetricarboxylic acid triamide compound, or a mixture of a benzenetricarboxylic acid triamide compound and a benzenetricarboxylic acid diamide compound, and most preferably a benzenetricarboxylic acid triamide compound. is there.
【0029】本発明のゲル化または固化剤の使用法は、
前記有機液体1mLに対し、本発明のゲル化または固化
剤を1〜50mg、好ましくは2〜20mg添加し、所
望により60〜120℃程度に加熱して均一状態になる
まで攪拌した後、常温にて静置すれば、ゲル化物または
固化物を調製することができる。このものは均一なゲル
化物または固化物であり、常温で液体部分を生じること
なく、また、長期間の保存においても液体部分の発生は
ない。このようにして調製されたゲル化物または固化物
を塗料、インク、潤滑油、化粧品、医薬品、農業分野の
基剤もしくは製剤とすることができる。The use of the gelling or solidifying agent of the present invention is as follows:
To 1 mL of the organic liquid, 1 to 50 mg, preferably 2 to 20 mg, of the gelling or solidifying agent of the present invention is added, and if necessary, the mixture is heated to about 60 to 120 ° C., stirred until a uniform state is obtained, and then cooled to room temperature. When left to stand, a gelled or solidified product can be prepared. This is a uniform gel or solid, and does not generate a liquid portion at room temperature, and does not generate a liquid portion even during long-term storage. The gelled or solidified product thus prepared can be used as a base or formulation in the fields of paints, inks, lubricating oils, cosmetics, pharmaceuticals, and agriculture.
【0030】なお本発明のゲル化または固化剤は単独で
も使用できるが、本発明の目的を逸脱しないかぎり、従
来公知のゲル化剤、天然ワックスまたは合成ワックス等
の固化剤等を適量併用してもよい。Although the gelling or solidifying agent of the present invention can be used alone, it may be used in combination with a conventionally known gelling agent, a solidifying agent such as a natural wax or a synthetic wax in an appropriate amount without departing from the object of the present invention. Is also good.
【0031】[0031]
【実施例】実施例1 攪拌機、温度計、窒素ガス吹込管及び水分離器を取付け
た四ツ口フラスコ中で、ベンジルオキシカルボニルL−
バリン(東京化成(株)製、試薬)9.22g(0.0
37モル)を200mLの乾燥酢酸エチルに溶かし、氷
冷下でジシクロヘキシルカルボジイミド(東京化成
(株)製、試薬)8.33g(0.040モル)を加え
た。そのまま1時間攪拌した後、ドデシルアミン6.8
0g(0.037モル)を加え、一旦70℃に加熱し、
続いて室温まで放冷した。このとき生成したゲルを50
mLのアセトンを加えてよく砕き、不溶物を吸引濾取
し、アセトンでよく洗って、室温で乾燥した。8.17
gの白色固体物を得た。このものを250mLのエタノ
ールに溶解させ、パラジウム炭素を溶解50mLエタノ
ールを加えた後、水素ガスを注入し還元を行った。還元
終了後触媒を除去し、溶剤を留去してからエタノールよ
り再結晶し、L−バリルドデシルアミド4.16gを得
た。次にL−バリルドデシルアミド0.57g(0.0
02モル)とフタロイルクロライド0.20g(0.0
01モル)を乾燥テトラヒドロフランに溶解させ、氷冷
下でトリエチルアミン0.70mL(0.005モル)
を加え室温まで攪拌した後、加熱して反応を完結させ
た。その後溶剤を留去しエタノールより再結晶を行い、
フタル酸ジアミド化合物(化合物1)0.20gを得
た。EXAMPLE 1 In a four-necked flask equipped with a stirrer, thermometer, nitrogen gas inlet tube and water separator, benzyloxycarbonyl L- was added.
9.22 g of valine (Tokyo Kasei Co., Ltd. reagent)
37 mol) was dissolved in 200 mL of dry ethyl acetate, and under ice cooling, 8.33 g (0.040 mol) of dicyclohexylcarbodiimide (manufactured by Tokyo Chemical Industry Co., Ltd.) was added. After stirring for 1 hour, dodecylamine 6.8 was added.
0 g (0.037 mol) was added and heated to 70 ° C. once,
Subsequently, it was allowed to cool to room temperature. The gel generated at this time is 50
The mixture was crushed by adding mL of acetone, and the insolubles were collected by suction filtration, washed well with acetone, and dried at room temperature. 8.17
g of a white solid were obtained. This was dissolved in 250 mL of ethanol, palladium carbon was dissolved, 50 mL of ethanol was added, and hydrogen gas was injected to perform reduction. After completion of the reduction, the catalyst was removed, the solvent was distilled off, and the residue was recrystallized from ethanol to obtain 4.16 g of L-validodecylamide. Next, 0.57 g of L-validodecylamide (0.0
02 mol) and 0.20 g (0.0%) of phthaloyl chloride.
01 mol) in dry tetrahydrofuran, and 0.70 mL (0.005 mol) of triethylamine under ice-cooling.
After stirring to room temperature, the reaction was completed by heating. After that, the solvent was distilled off and recrystallized from ethanol.
0.20 g of a phthalic diamide compound (Compound 1) was obtained.
【0032】 [0032]
【0033】実施例2 前記実施例1のフタロイルクロライドをイソフタロイル
クロライドに代えて、その他実施例1記載の方法と同様
にして、イソフタル酸ジアミド化合物(化合物11)
0.51gを得た。Example 2 An isophthalic acid diamide compound (compound 11) was prepared in the same manner as in Example 1 except that phthaloyl chloride in Example 1 was replaced with isophthaloyl chloride.
0.51 g was obtained.
【0034】 [0034]
【0035】実施例3 前記実施例1で用いたベンジルオキシカルボニルL−バ
リンの代わりにベンジルオキシカルボニルL−イソロイ
シンを用いて、実施例1記載の方法と同様にしてL−イ
ソロイシルドデシルアミドを得た。その後、前記実施例
1のフタロイルクロライドをイソフタロイルクロライド
に代えて、実施例1記載の方法と同様にして、イソフタ
ル酸ジアミド化合物(化合物12)0.43gを得た。Example 3 L-isoleucyldodecylamide was prepared in the same manner as in Example 1 except that benzyloxycarbonyl L-isoleucine was used in place of benzyloxycarbonyl L-valine used in Example 1 above. Obtained. Thereafter, 0.43 g of an isophthalic acid diamide compound (Compound 12) was obtained in the same manner as in Example 1 except that phthaloyl chloride in Example 1 was replaced with isophthaloyl chloride.
【0036】 [0036]
【0037】実施例4 前記実施例1のドデシルアミンの代わりにオクタデシル
アミンを用いて、実施例1記載の方法と同様にしてL−
バリルオクタデシルアミドを得た。その後、前記実施例
1のフタロイルクロライドをイソフタロイルクロライド
に代えて、実施例1記載の方法と同様にして、イソフタ
ル酸ジアミド化合物(化合物13)0.72gを得た。Example 4 The procedure of Example 1 was repeated, except that octadecylamine was used in place of dodecylamine of Example 1 to obtain L-
Valyl octadecylamide was obtained. Thereafter, 0.72 g of an isophthalic acid diamide compound (compound 13) was obtained in the same manner as in Example 1 except that phthaloyl chloride in Example 1 was replaced with isophthaloyl chloride.
【0038】 [0038]
【0039】実施例5 前記実施例1で用いたベンジルオキシカルボニルL−バ
リンの代わりに、ベンジルオキシカルボニルD,L−バ
リン、ドデシルアミンの代わりにオクタデシルアミンを
用いて、実施例1記載の方法と同様にしてD,L−バリ
ルオクタデシルアミドを得た。その後、前記実施例1の
フタロイルクロライドをイソフタロイルクロライドに代
えて、実施例1記載の方法と同様にしてイソフタル酸ジ
アミド化合物(化合物14)0.97gを得た。Example 5 The method described in Example 1 was repeated, except that benzyloxycarbonyl D, L-valine and octadecylamine were used instead of benzyloxycarbonyl D, L-valine and dodecylamine used in Example 1 above. Similarly, D, L-valyl octadecylamide was obtained. Thereafter, 0.97 g of an isophthalic acid diamide compound (Compound 14) was obtained in the same manner as in Example 1 except that phthaloyl chloride of Example 1 was replaced with isophthaloyl chloride.
【0040】 [0040]
【0041】実施例6 前記実施例1のフタロイルクロライドをテレフタロイル
クロライドに代えて、その他実施例1記載の方法と同様
にして、テレフタル酸ジアミド化合物(化合物22)
0.57gを得た。Example 6 A terephthalic acid diamide compound (compound 22) was prepared in the same manner as in Example 1 except that phthaloyl chloride in Example 1 was replaced with terephthaloyl chloride.
0.57 g was obtained.
【0042】 [0042]
【0043】実施例7 前記実施例1で用いたベンジルオキシカルボニルL−バ
リンの代わりにベンジルオキシカルボニルグリシンを用
いて、実施例1記載の方法と同様にしてグリシルドデシ
ルアミドを得た。その後、前記実施例1のフタロイルク
ロライドをテレフタロイルクロライドに代えて、実施例
1記載の方法と同様にしてテレフタル酸ジアミド化合物
(化合物23)0.54gを得た。Example 7 Glycyl dodecylamide was obtained in the same manner as in Example 1, except that benzyloxycarbonyl glycine was used instead of benzyloxycarbonyl L-valine used in Example 1. Thereafter, 0.54 g of a terephthalic acid diamide compound (Compound 23) was obtained in the same manner as in Example 1, except that phthaloyl chloride in Example 1 was replaced with terephthaloyl chloride.
【0044】 [0044]
【0045】実施例8 前記実施例1で用いたベンジルオキシカルボニルL−バ
リンの代わりにベンジルオキシカルボニルL−ロイシン
を用いて、実施例1記載の方法と同様にしてL−ロイシ
ルドデシルアミドを得た。その後、前記実施例1のフタ
ロイルクロライドをテレフタロイルクロライドに代え
て、実施例1記載の方法と同様にしてテレフタル酸ジア
ミド化合物(化合物24)0.45gを得た。Example 8 L-leucyldodecylamide was obtained in the same manner as in Example 1 except that benzyloxycarbonyl L-leucine was used instead of benzyloxycarbonyl L-valine used in Example 1 above. Was. Thereafter, 0.45 g of a terephthalic acid diamide compound (compound 24) was obtained in the same manner as in Example 1, except that phthaloyl chloride in Example 1 was replaced with terephthaloyl chloride.
【0046】 [0046]
【0047】実施例9 前記実施例で用いたベンジルオキシカルボニルL−バリ
ンの代わりにベンジルオキシカルボニルL−イソロイシ
ンを用いて、実施例1記載の方法と同様にしてL−イソ
ロイシルドデシルアミドを得た。その後、前記実施例1
のフタロイルクロライドをテレフタロイルクロライドに
代えて、実施例1記載の方法と同様にしてテレフタル酸
ジアミド化合物(化合物25)0.37gを得た。Example 9 L-isoleucyldodecylamide was obtained in the same manner as in Example 1 except that benzyloxycarbonyl L-isoleucine was used instead of benzyloxycarbonyl L-valine used in the above example. Was. Then, the first embodiment
Was replaced with terephthaloyl chloride to obtain 0.37 g of a terephthalic acid diamide compound (compound 25) in the same manner as in Example 1.
【0048】 [0048]
【0049】実施例10 前記実施例1のドデシルアミンの代わりにオクタデシル
アミンを用いて、実施例1記載の方法と同様にしてL−
バリルオクタデシルアミドを得た。その後、前記実施例
1のフタロイルクロライドをテレフタロイルクロライド
に代えて、実施例1記載の方法と同様にして、テレフタ
ル酸ジアミド化合物(化合物26)0.80gを得た。Example 10 The procedure of Example 1 was repeated, except that octadecylamine was used instead of dodecylamine.
Valyl octadecylamide was obtained. Thereafter, 0.80 g of a terephthalic acid diamide compound (compound 26) was obtained in the same manner as in Example 1, except that phthaloyl chloride in Example 1 was replaced with terephthaloyl chloride.
【0050】 [0050]
【0051】実施例11 前記実施例1で用いたベンジルオキシカルボニルL−バ
リンの代わりにベンジルオキシカルボニルL−ロイシ
ン、ドデシルアミンの代わりにオクタデシルアミンを用
いて、実施例1記載の方法と同様にしてL−ロイシルオ
クタデシルアミドを得た。その後、前記実施例1のフタ
ロイルクロライドをテレフタロイルクロライドに代え
て、実施例1記載の方法と同様にしてテレフタル酸ジア
ミド化合物(化合物27)0.53gを得た。Example 11 In the same manner as in Example 1, except that benzyloxycarbonyl L-leucine was used instead of benzyloxycarbonyl L-valine and octadecylamine was used instead of dodecylamine used in Example 1 above. L-Leucyloctadecylamide was obtained. Thereafter, 0.53 g of a terephthalic acid diamide compound (compound 27) was obtained in the same manner as in Example 1, except that phthaloyl chloride in Example 1 was replaced with terephthaloyl chloride.
【0052】 [0052]
【0053】実施例12 前記実施例1で用いたベンジルオキシカルボニルL−バ
リンの代わりにベンジルオキシカルボニルL−イソロイ
シン、ドデシルアミンの代わりにオクタデシルアミンを
用いて、実施例1記載の方法と同様にしてL−イソロイ
シルオクタデシルアミドを得た。その後、前記実施例1
のフタロイルクロライドをテレフタロイルクロライドに
代えて、実施例1記載の方法と同様にしてテレフタル酸
ジアミド化合物(化合物28)0.63gを得た。Example 12 The procedure of Example 1 was repeated, except that benzyloxycarbonyl L-isoleucine was used in place of benzyloxycarbonyl L-valine and octadecylamine was used in place of dodecylamine. L-isoleucyl octadecylamide was obtained. Then, the first embodiment
Was replaced with terephthaloyl chloride to obtain 0.63 g of a terephthalic acid diamide compound (compound 28) in the same manner as in Example 1.
【0054】 [0054]
【0055】実施例13 前記実施例1で用いたベンジルオキシカルボニルL−バ
リンの代わりにベンジルオキシカルボニルD,L−バリ
ン、ドデシルアミンの代わりにオクタデシルアミンを用
いて、実施例1記載の方法と同様にしてD,L−バリル
オクタデシルアミドを得た。その後、前記実施例1のフ
タロイルクロライドをテレフタロイルクロライドに代え
て、実施例1記載の方法と同様にしてテレフタル酸ジア
ミド化合物(化合物29)0.88gを得た。Example 13 The same procedure as in Example 1 was repeated, except that benzyloxycarbonyl D, L-valine was used instead of benzyloxycarbonyl L-valine and octadecylamine was used instead of dodecylamine. Thus, D, L-valyloctadecylamide was obtained. Thereafter, the phthaloyl chloride of Example 1 was replaced with terephthaloyl chloride to obtain 0.88 g of a terephthalic acid diamide compound (compound 29) in the same manner as in Example 1.
【0056】 [0056]
【0057】実施例14 前記実施例1のフタロイルクロライドを1,3,5−ベ
ンゼントリカルボニルトリクロライドに代え、かつ1,
3,5−ベンゼントリカルボニルトリクロライドに対し
て3倍モル量のL−バリルドデシルアミドを反応させ
て、その他実施例1記載の方法と同様にして1,3,5
−ベンゼントリカルボン酸トリアミド化合物(化合物4
1)0.96gを得た。Example 14 The phthaloyl chloride of Example 1 was replaced with 1,3,5-benzenetricarbonyltrichloride and
A 3-fold molar amount of L-validodecylamide was reacted with 3,5-benzenetricarbonyltrichloride, and 1,3,5 was obtained in the same manner as in Example 1.
-Benzenetricarboxylic acid triamide compound (compound 4
1) 0.96 g was obtained.
【0058】 [0058]
【0059】実施例15 前記実施例で用いたベンジルオキシカルボニルL−バリ
ンの代わりに、ベンジルオキシカルボニルL−ロイシン
を用いて、実施例1記載の方法と同様にしてL−ロイシ
ルドデシルアミドを得た。その後、前記実施例1のフタ
ロイルクロライドを1,3,5−ベンゼントリカルボニ
ルトリクロライドに代え、かつ1,3,5−ベンゼント
リカルボニルトリクロライドに対して3倍モル量のL−
ロイシルドデシルアミドを反応させて、その他実施例1
記載の方法と同様にして、1,3,5−ベンゼントリカ
ルボン酸トリアミド化合物(化合物42)0.99gを
得た。Example 15 L-leucyldodecylamide was obtained in the same manner as in Example 1 except that benzyloxycarbonyl L-leucine was used instead of benzyloxycarbonyl L-valine used in the above example. Was. Thereafter, the phthaloyl chloride of Example 1 was replaced with 1,3,5-benzenetricarbonyltrichloride, and L-molar amount of 3 times the amount of 1,3,5-benzenetricarbonyltrichloride was used.
Example 1 was reacted with leucyldodecylamide.
In the same manner as described, 0.99 g of a 1,3,5-benzenetricarboxylic acid triamide compound (compound 42) was obtained.
【0060】 [0060]
【0061】実施例16 本発明により得られたベンゼンカルボン酸アミド化合物
および対照としての12−ヒドロキシステアリン酸、ス
テアリン酸ナトリウム、カルナウバワックスの代表的な
有機液体に対するゲル化または固化能を試験した。各種
有機液体に本発明に係るゲル化または固化剤等を3重量
%添加したものを試験管に入れ、約60℃以上に加熱
後、常温(25℃)にて静置冷却したときの状態を観察
し、このときの内容物の流動性の有無、また流動性のな
いものについてはゲル化物の固さを調べた。評価は4段
階評価(◎…流動性なし:ゲル化物は均一で固い、○…
流動性なし:ゲル化物は均一で軟らかい、△…流動性や
やあり、×…不均一混合物または均一だが流動性あり)
で行った。Example 16 The ability of the benzenecarboxylic acid amide compound obtained according to the present invention and 12-hydroxystearic acid, sodium stearate and carnauba wax as controls to gel or solidify a typical organic liquid was tested. A mixture obtained by adding 3% by weight of the gelling or solidifying agent according to the present invention to various organic liquids is placed in a test tube, heated to about 60 ° C. or more, and then left to cool at room temperature (25 ° C.). At this time, the contents were examined for fluidity, and for those having no fluidity, the hardness of the gel was examined. The evaluation was performed on a four-point scale (◎: no fluidity: the gel was uniform and hard, ○:
No fluidity: The gel is uniform and soft, △: slightly fluid, ×: heterogeneous mixture or uniform but fluid
I went in.
【0062】実験結果を以下の表に示す。フタル酸ジア
ミド化合物を使用したゲル化または固化能についての結
果を表1に、イソフタル酸ジアミド化合物についての結
果を表2に、テレフタル酸ジアミド化合物についての結
果を表3に、ベンゼントリカルボン酸トリアミド化合物
についての結果を表4に示す。全ての表中、*i−C8
は2−エチルヘキシル基、**混合アミンの場合の配合
比率は1:1(モル比)であり、***混合アミノ酸の
場合の配合比率は1:1(モル比)である。また、表4
におけるベンゼントリカルボン酸トリアミド化合物は、
化合物43〜53は1,3,5−ベンゼントリカルボン
酸トリアミドであり、化合物54のみ1,2,4−ベン
ゼントリカルボン酸トリアミドであることに注意された
い。また、表4の化合物50と51、および化合物52
と53は、それぞれ2種の化合物の混合物(モル比1:
1)を表している。The experimental results are shown in the following table. Table 1 shows the results of the gelation or solidification ability using the phthalic acid diamide compound, Table 2 shows the results of the isophthalic acid diamide compound, and Table 3 shows the results of the terephthalic acid diamide compound. Table 4 shows the results. * I-C8 in all tables
Is a 2-ethylhexyl group, ** the mixing ratio in the case of a mixed amine is 1: 1 (molar ratio), and the *** mixing ratio in the case of a mixed amino acid is 1: 1 (molar ratio). Table 4
The benzene tricarboxylic acid triamide compound in
Note that compounds 43-53 are 1,3,5-benzenetricarboxylic triamides and only compound 54 is 1,2,4-benzenetricarboxylic triamide. Compounds 50 and 51 and Compound 52 in Table 4
And 53 are each a mixture of two compounds (molar ratio 1:
1).
【0063】[0063]
【表1】 [Table 1]
【0064】[0064]
【表2】 [Table 2]
【0065】[0065]
【表3】 [Table 3]
【0066】[0066]
【表4】 [Table 4]
【0067】本発明のカルボン酸アミド化合物を主成分
とするものを添加した有機液体は、従来のゲル化剤やワ
ックスに比べ少量の添加であるにもかかわらず、均一で
滑らかなゲル化物を形成することが明らかになった。ま
た調製したゲル化物を1ヵ月間にわたり毎日10〜30
℃の温度幅で変化させ、その状態を調べたところ、本発
明に係るものはすべて調製当初の状態を維持しており、
長期間の温度変化に対して安定性に優れていることを確
認した。The organic liquid to which the carboxylic acid amide compound of the present invention is added as a main component forms a uniform and smooth gelled product despite the addition of a smaller amount than conventional gelling agents and waxes. It turned out to be. Further, the gelled product prepared is prepared for 10 to 30 days every month for one month.
When the temperature was changed at a temperature range of ° C., and the state was examined, all those according to the present invention maintained the initial state of preparation,
It has been confirmed that it has excellent stability against long-term temperature changes.
【0068】[0068]
【発明の効果】本発明によれば、前記一般式(I)で示
されるカルボン酸アミド化合物が提供され、これを有効
成分とするゲル化もしくは固化剤は、動植物油脂、エス
テル、ポリオール、エーテル、アルコール、炭化水素系
油剤等の幅広い有機液体に対し、あるいは廃食用油、廃
潤滑油、廃金属加工油剤等に対して、少量の添加で、均
一で良好な、長期保存および温度変化に対して安定性に
優れたゲル化物または固化物を調製し得る。According to the present invention, there is provided a carboxylic acid amide compound represented by the above general formula (I), and the gelling or solidifying agent containing the carboxylic acid amide compound as an active ingredient is an animal or vegetable oil, an ester, a polyol, an ether, For a wide range of organic liquids such as alcohols and hydrocarbon oils, or for waste cooking oil, waste lubricating oil, waste metal processing oil, etc. A gel or solid having excellent stability can be prepared.
フロントページの続き Fターム(参考) 4G065 AA05 AA10 AB01Y AB02X AB02Y AB03X AB11Y AB16Y AB17Y AB18Y AB29X BA09 BA20 BB02 BB08 CA16 DA02 DA03 DA04 DA05 DA06 DA07 4G075 AA33 AA37 CA02 CA03 4H006 AA01 AA03 AB90 BJ50 BV22 BV72 4H059 BA49 BB14 BC03 BC13 CA94 DA13 DA14 EA40 Continued on the front page F-term (reference) 4G065 AA05 AA10 AB01Y AB02X AB02Y AB03X AB11Y AB16Y AB17Y AB18Y AB29X BA09 BA20 BB02 BB08 CA16 DA02 DA03 DA04 DA05 DA06 DA07 4G075 AA33 AA37 CA02 CA03 4H006 AA01 AA4B39 BBA90 BC90 BC DA13 DA14 EA40
Claims (4)
−NHRを表し、AAはアミノ酸アシル基、各Rは炭素
数8〜22のアルキル基、nは1または2を表す)で示
されるベンゼンカルボン酸アミド化合物。1. A compound represented by the following general formula (I) (In the general formula (I), X 1 and X 2 each represent -AA
Benzenecarboxylic acid amide compound represented by -NHR, AA represents an amino acid acyl group, each R represents an alkyl group having 8 to 22 carbon atoms, and n represents 1 or 2.
−NHRを表し、AAはアミノ酸アシル基、各Rは炭素
数8〜22のアルキル基、nは1または2を表す)で示
されるベンゼンカルボン酸アミド化合物を有効成分とす
る有機液体のゲル化または固化剤。2. The following general formula (I): (In the general formula (I), X 1 and X 2 each represent -AA
AA represents an amino acid acyl group, each R represents an alkyl group having 8 to 22 carbon atoms, and n represents 1 or 2). Solidifying agent.
ト位にあるとき、X1およびX2 それぞれ−AA−NH
Rを表し、各AAはL−バリルであり、かつ各Rは炭素
数12のアルキル基であり、 nが1であって、かつCOX2 がCOX1 に対してメタ
位にあるとき、X1 およびX2 はそれぞれ−AA−NH
Rを表し、各AAはL−バリルまたはL−イソロイシル
であって、かつ各Rは炭素数12のアルキル基である
か、または各AAはL−バリルまたはD,L−バリルで
あって、かつ各Rは炭素数18のアルキル基であり、 nが1であって、かつCOX2 がCOX1 に対してパラ
位にあるとき、X1 およびX2 はそれぞれ−AA−NH
Rを表し、各AAはL−バリル、グリシル、L−ロイシ
ルまたはL−イソロイシルであって、かつ各Rは炭素数
12のアルキル基であるか、または各AAはL−バリ
ル、L−ロイシル、L−イソロイシルまたはD,L−バ
リルであって、かつ各Rは炭素数18のアルキル基であ
り、 nが2のとき、2つのCOX2 はCOX1 に対して共に
メタ位にあり、X1 およびX2 はそれぞれ−AA−NH
Rを表し、各AAはL−バリルまたはL−ロイシルであ
って、かつ各Rは炭素数12のアルキル基である)で示
されるベンゼンカルボン酸アミド化合物。3. The following general formula (I): (In the general formula (I), n is 1 or 2, and when n is 1 and COX 2 is ortho to COX 1 , X 1 and X 2 are each -AA-NH
R represents each AA is L-valyl, and each R is an alkyl group having 12 carbon atoms, when n is 1 and COX 2 is in the meta position to COX 1 , X 1 And X 2 are each -AA-NH
Represents R, each AA is L-valyl or L-isoleucyl, and each R is an alkyl group having 12 carbon atoms, or each AA is L-valyl or D, L-valyl, and When each R is an alkyl group having 18 carbon atoms, n is 1 and COX 2 is in the para position with respect to COX 1 , X 1 and X 2 are each -AA-NH
Represents R, each AA is L-valyl, glycyl, L-leucyl or L-isoleucyl, and each R is an alkyl group having 12 carbon atoms, or each AA is L-valyl, L-leucyl, L-isoleucyl or D, L-valyl, and each R is an alkyl group having 18 carbon atoms. When n is 2, two COX 2 are both meta-position to COX 1 and X 1 And X 2 are each -AA-NH
Wherein each AA is L-valyl or L-leucyl, and each R is an alkyl group having 12 carbon atoms).
ト位にあるとき、X1およびX2 はそれぞれ−AA−N
HRを表し、各AAはL−バリルであり、かつ各Rは炭
素数12のアルキル基であり、 nが1であって、かつCOX2 がCOX1 に対してメタ
位にあるとき、X1 およびX2 はそれぞれ−AA−NH
Rを表し、各AAはL−バリルまたはL−イソロイシル
であって、かつ各Rは炭素数12のアルキル基である
か、または各AAはL−バリルまたはD,L−バリルで
あって、かつ各Rは炭素数18のアルキル基であり、 nが1であって、かつCOX2 がCOX1 に対してパラ
位にあるとき、X1 およびX2 はそれぞれ−AA−NH
Rを表し、各AAはL−バリル、グリシル、L−ロイシ
ルまたはL−イソロイシルであって、かつ各Rは炭素数
12のアルキル基であるか、または各AAはL−バリ
ル、L−ロイシル、L−イソロイシルまたはD,L−バ
リルであって、かつ各Rは炭素数18のアルキル基であ
り、 nが2のとき、2つのCOX2 はCOX1 に対して共に
メタ位にあり、X1 およびX2 はそれぞれ−AA−NH
Rを表し、各AAはL−バリルまたはL−ロイシルであ
って、かつ各Rは炭素数12のアルキル基である)で示
されるベンゼンカルボン酸アミド化合物よりなる群から
選ばれた化合物を有効成分とする有機液体のゲル化また
は固化剤。4. The following general formula (I): (In the general formula (I), n is 1 or 2, and when n is 1 and COX 2 is ortho to COX 1 , X 1 and X 2 are each -AA-N
HR, each AA is L-valyl, and each R is an alkyl group having 12 carbon atoms, when n is 1 and COX 2 is in the meta position to COX 1 , X 1 And X 2 are each -AA-NH
Represents R, each AA is L-valyl or L-isoleucyl, and each R is an alkyl group having 12 carbon atoms, or each AA is L-valyl or D, L-valyl, and When each R is an alkyl group having 18 carbon atoms, n is 1 and COX 2 is in the para position with respect to COX 1 , X 1 and X 2 are each -AA-NH
Represents R, each AA is L-valyl, glycyl, L-leucyl or L-isoleucyl, and each R is an alkyl group having 12 carbon atoms, or each AA is L-valyl, L-leucyl, L-isoleucyl or D, L-valyl, and each R is an alkyl group having 18 carbon atoms. When n is 2, two COX 2 are both meta-position to COX 1 and X 1 And X 2 are each -AA-NH
Wherein each AA is L-valyl or L-leucyl, and each R is an alkyl group having 12 carbon atoms, a compound selected from the group consisting of benzenecarboxylic acid amide compounds represented by the formula: A gelling or solidifying agent for an organic liquid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24696598A JP3641143B2 (en) | 1998-09-01 | 1998-09-01 | Benzenecarboxylic acid amide compounds and organic liquid gelling or solidifying agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24696598A JP3641143B2 (en) | 1998-09-01 | 1998-09-01 | Benzenecarboxylic acid amide compounds and organic liquid gelling or solidifying agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000072736A true JP2000072736A (en) | 2000-03-07 |
JP3641143B2 JP3641143B2 (en) | 2005-04-20 |
Family
ID=17156367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP24696598A Expired - Fee Related JP3641143B2 (en) | 1998-09-01 | 1998-09-01 | Benzenecarboxylic acid amide compounds and organic liquid gelling or solidifying agents |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3641143B2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1364941A1 (en) * | 2002-05-22 | 2003-11-26 | Applied NanoSystems B.V. | Gelling agents |
WO2005047231A1 (en) * | 2003-11-12 | 2005-05-26 | Applied Nanosystems B.V. | Non-symmetrical gelling agent |
WO2008074227A1 (en) * | 2006-12-19 | 2008-06-26 | Versitech Limited | Synthetic ion channels |
CN101912756A (en) * | 2010-08-17 | 2010-12-15 | 上海交通大学 | 1,4-cyclohexane diformyl based preparation method of transparent hydrogel |
JP2013124252A (en) * | 2011-12-15 | 2013-06-24 | Xerox Corp | Organic gel composition including alkylated aromatic acid |
WO2014051057A1 (en) * | 2012-09-27 | 2014-04-03 | 国立大学法人神戸大学 | Gelling agent |
US8697758B2 (en) | 2008-09-24 | 2014-04-15 | National University Corporation Shizuoka University | Urea compound, self-assembly of urea compounds, organogel containing self-assembly, and method for producing organogel |
US9610263B2 (en) | 2007-12-19 | 2017-04-04 | Versitech Limited | Method of modulating membrane potential of a cell |
-
1998
- 1998-09-01 JP JP24696598A patent/JP3641143B2/en not_active Expired - Fee Related
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1364941A1 (en) * | 2002-05-22 | 2003-11-26 | Applied NanoSystems B.V. | Gelling agents |
WO2003097587A3 (en) * | 2002-05-22 | 2004-03-11 | Applied Nanosystems Bv | Gelling agents |
CN100381418C (en) * | 2002-05-22 | 2008-04-16 | 应用超微系统股份有限公司 | Gelling agents |
US7645805B2 (en) | 2002-05-22 | 2010-01-12 | Applied Nanosystems, B.V. | Gelling agents |
WO2005047231A1 (en) * | 2003-11-12 | 2005-05-26 | Applied Nanosystems B.V. | Non-symmetrical gelling agent |
JP2007510791A (en) * | 2003-11-12 | 2007-04-26 | アプライド ナノ システムズ ベー.フェー. | Asymmetric gelling agent |
JP4741505B2 (en) * | 2003-11-12 | 2011-08-03 | アプライド ナノ システムズ ベー.フェー. | Asymmetric gelling agent |
US7534915B2 (en) | 2003-11-12 | 2009-05-19 | Applied Nanosystems B.V. | Non-symmetrical gelling agent |
JP2010513332A (en) * | 2006-12-19 | 2010-04-30 | バーシテック、リミテッド | Synthetic ion channel |
WO2008074227A1 (en) * | 2006-12-19 | 2008-06-26 | Versitech Limited | Synthetic ion channels |
US8378138B2 (en) | 2006-12-19 | 2013-02-19 | The University of Hong Kong & Versitech Limited | Synthetic ion channels |
US9610263B2 (en) | 2007-12-19 | 2017-04-04 | Versitech Limited | Method of modulating membrane potential of a cell |
US8697758B2 (en) | 2008-09-24 | 2014-04-15 | National University Corporation Shizuoka University | Urea compound, self-assembly of urea compounds, organogel containing self-assembly, and method for producing organogel |
CN101912756A (en) * | 2010-08-17 | 2010-12-15 | 上海交通大学 | 1,4-cyclohexane diformyl based preparation method of transparent hydrogel |
JP2013124252A (en) * | 2011-12-15 | 2013-06-24 | Xerox Corp | Organic gel composition including alkylated aromatic acid |
WO2014051057A1 (en) * | 2012-09-27 | 2014-04-03 | 国立大学法人神戸大学 | Gelling agent |
JPWO2014051057A1 (en) * | 2012-09-27 | 2016-08-25 | 国立大学法人神戸大学 | Gelling agent |
Also Published As
Publication number | Publication date |
---|---|
JP3641143B2 (en) | 2005-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1127158A (en) | Anionic surfactants having multiple hydrophobic and hydrophilic groups | |
US9464036B2 (en) | Thickening stabilizer, and thickening/stabilizing composition using the same | |
JP2000072736A (en) | Benzenecarboxamide compound and gelling agent or solidifying agent for organic liquid | |
CN101993568B (en) | Anti-adhesion agent composition for asphalt | |
HU184618B (en) | Surface active materials containing carboxyl group stable in hard water | |
KR20140143353A (en) | Method for preparing mono or dialkanol amides | |
Abdul Rub | Aggregation and interfacial phenomenon of amphiphilic drug under the influence of pharmaceutical excipients (green/biocompatible gemini surfactant) | |
JP2000256303A (en) | Gelling agent for solidifying agent for liquid organic medium | |
JP4543692B2 (en) | Basic amino acid derivatives | |
JP3171863B2 (en) | Amphoteric surfactant composition | |
WO2004096754A1 (en) | Two-headed basic amino acid derivative | |
JPH08231942A (en) | Gelling or solidifying agent for organic liquid | |
JP5347104B2 (en) | Gelling agent | |
Rondel et al. | Synthesis and properties of lipoamino acid–fatty acid mixtures: influence of the amphiphilic structure | |
TW201741280A (en) | N-alkyldiamide compounds and gels comprising the same | |
JP3500289B2 (en) | Thickening and gelling agent composed of cyclohexanetricarboxamide derivative | |
US8187579B2 (en) | Thickening agent | |
JP2021528474A (en) | Ester amine salt | |
EP1094059B1 (en) | Process for production of N-acyl amino acid amide | |
JP3061348B2 (en) | Gelling agents for organic solvents and / or fats and oils | |
JP4137494B2 (en) | Method for producing weakly acidic transparent solid detergent | |
JPS60116791A (en) | Water-soluble corrosion preventive | |
JP3357414B2 (en) | Foaming agent | |
US6274748B1 (en) | Process for the manufacture of compounds containing a fatty acid moiety | |
JP3261833B2 (en) | Method for producing detergent composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20040701 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050111 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050120 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080128 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110128 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110128 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140128 Year of fee payment: 9 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |